Blennow Kaj

Top coauthors of Blennow Kaj

Zetterberg Henrik (431 papers)

Minthon Lennart (94 papers)

Andreasson Ulf (92 papers)

Hansson Oskar (81 papers)

Mattsson Niklas (74 papers)

List of Blennow Kaj publications

2016

Novakova Lenka, Axelsson Markus, Khademi Mohsen, Zetterberg Henrik, Blennow Kaj, et al. 2016. "Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis." Journal of neurochemistry doi:10.1111/jnc.13881
Mañé-Martínez M Alba, Olsson Bob, Bau Laura, Matas Elisabet, Cobo-Calvo Álvaro, et al. 2016. "Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis." Journal of neuroimmunology 299 doi:10.1016/j.jneuroim.2016.08.004
Lewczuk Piotr, Matzen Anja, Blennow Kaj, Parnetti Lucilla, Molinuevo Jose Luis, et al. 2016. "Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-160722
Öhrfelt Annika, Brinkmalm Ann, Dumurgier Julien, Brinkmalm Gunnar, Hansson Oskar, et al. 2016. "The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease." Alzheimer's research & therapy 8 (1) doi:10.1186/s13195-016-0208-8
Bergman Joakim, Dring Ann, Zetterberg Henrik, Blennow Kaj, Norgren Niklas, et al. 2016. "Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS." Neurology® neuroimmunology & neuroinflammation 3 (5) doi:10.1212/NXI.0000000000000271
Mattsson Niklas, Zetterberg Henrik, Janelidze Shorena, Insel Philip S, Andreasson Ulf, et al. 2016. "Plasma tau in Alzheimer disease." Neurology doi:10.1212/WNL.0000000000003246
Lövheim Hugo, Elgh Fredrik, Johansson Anders, Zetterberg Henrik, Blennow Kaj, et al. 2016. "Plasma concentrations of free amyloid-β cannot predict the development of Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association doi:10.1016/j.jalz.2016.08.016
Leyhe Thomas, Reynolds Charles F, Melcher Tobias, Linnemann Christoph, Klöppel Stefan, et al. 2016. "A common challenge in older adults: Classification, overlap, and therapy of depression and dementia." Alzheimer's & dementia : the journal of the Alzheimer's Association doi:10.1016/j.jalz.2016.08.007
Idland Ane-Victoria, Sala-Llonch Roser, Borza Tom, Watne Leiv Otto, Wyller Torgeir Bruun, et al. 2016. "CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults." Neurobiology of aging 49 doi:10.1016/j.neurobiolaging.2016.09.012
Darst Burcu F, Koscik Rebecca L, Racine Annie M, Oh Jennifer M, Krause Rachel A, et al. 2016. "Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-160195
Arnerić Stephen P, Batrla-Utermann Richard, Beckett Laurel, Bittner Tobias, Blennow Kaj, et al. 2016. "Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-160573
Steen Jensen Camilla, Portelius Erik, Siersma Volkert, Høgh Peter, Wermuth Lene, et al. 2016. "Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease." Dementia and geriatric cognitive disorders 42 (3-4) doi:10.1159/000449408
Idland Ane-Victoria, Wyller Torgeir Bruun, Støen Randi, Eri Lars Magne, Frihagen Frede, et al. 2016. "Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-160461
Lewczuk Piotr, Lelental Natalia, Lachmann Ingolf, Holzer Max, Flach Katharina, et al. 2016. "Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-160448
Shahim Pashtun, Blennow Kaj, Johansson Per, Svensson Johan, Lista Simone, et al. 2016. "Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders." Neuromolecular medicine doi:10.1007/s12017-016-8439-1
Shahim Pashtun, Tegner Yelverton, Gustafsson Bengt, Gren Magnus, Ärlig Johan, et al. 2016. "Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury." JAMA neurology doi:10.1001/jamaneurol.2016.2038
Zetterberg Henrik, Blennow Kaj 2016. "Fluid biomarkers for mild traumatic brain injury and related conditions." Nature reviews. Neurology doi:10.1038/nrneurol.2016.127
Russell Claire L, Mitra Vikram, Hansson Karl, Blennow Kaj, Gobom Johan, et al. 2016. "Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-160633
Remnestål Julia, Just David, Mitsios Nicholas, Fredolini Claudia, Mulder Jan, et al. 2016. "CSF profiling of the human brain-enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease." Proteomics. Clinical applications doi:10.1002/prca.201500150
Portelius Erik, Durieu Emilie, Bodin Marion, Cam Morgane, Pannee Josef, et al. 2016. "Specific Triazine Herbicides Induce Amyloid-β42 Production." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-160310
Racine Annie M, Clark Lindsay R, Berman Sara E, Koscik Rebecca L, Mueller Kimberly D, et al. 2016. "Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-160528
Rohrer Jonathan D, Woollacott Ione O C, Dick Katrina M, Brotherhood Emilie, Gordon Elizabeth, et al. 2016. "Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia." Neurology doi:10.1212/WNL.0000000000003154
Pannee Josef, Portelius Erik, Minthon Lennart, Gobom Johan, Andreasson Ulf, et al. 2016. "Reference measurement procedure for CSF Aβ1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against Amyloid PET." Journal of neurochemistry doi:10.1111/jnc.13838
Sandin Linnea, Bergkvist Liza, Nath Sangeeta, Kielkopf Claudia, Janefjord Camilla, et al. 2016. "Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster." The FEBS journal doi:10.1111/febs.13830
Ljungqvist Johan Carl, Zetterberg Henrik, Mitsis Marios, Blennow Kaj, Skoglund Thomas S 2016. "Serum neurofilament light protein as a marker for diffuse axonal injury - results from a case series study." Journal of neurotrauma doi:10.1089/neu.2016.4496
Varga Andrew W, Wohlleber Margaret E, Giménez Sandra, Romero Sergio, Alonso Joan F, et al. 2016. "Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly." Sleep doi:
Kern Jürgen, Kern Silke, Blennow Kaj, Zetterberg Henrik, Waern Margda, et al. 2016. "Calcium supplementation and risk of dementia in women with cerebrovascular disease." Neurology doi:10.1212/WNL.0000000000003111
Mattsson Niklas, Insel Philip S, Palmqvist Sebastian, Portelius Erik, Zetterberg Henrik, et al. 2016. "Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease." EMBO molecular medicine doi:10.15252/emmm.201606540
Sanfilippo Cristina, Forlenza Orestes, Zetterberg Henrik, Blennow Kaj 2016. "Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD." Journal of neural transmission (Vienna, Austria : 1996) doi:10.1007/s00702-016-1597-3
Pomara Nunzio, Bruno Davide, Osorio Ricardo S, Reichert Chelsea, Nierenberg Jay, et al. 2016. "State-dependent alterations in cerebrospinal fluid Aβ42 levels in cognitively intact elderly with late-life major depression." Neuroreport doi:10.1097/WNR.0000000000000658
Førland Marthe Gurine, Öhrfelt Annika, Oftedal Linn Silje, Tysnes Ole-Bjørn, Larsen Jan Petter, et al. 2016. "Validation of a new assay for α-synuclein detection in cerebrospinal fluid." Clinical chemistry and laboratory medicine doi:10.1515/cclm-2016-0409
Anderson Albert M, Lennox Jeffrey L, Mulligan Mark M, Loring David W, Zetterberg Henrik, et al. 2016. "Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals." Journal of neurovirology doi:10.1007/s13365-016-0466-z
Gren Magnus, Shahim Pashtun, Lautner Ronald, Wilson David H, Andreasson Ulf, et al. 2016. "Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving." Brain injury doi:10.1080/02699052.2016.1179792
Leuzy Antoine, Chiotis Konstantinos, Hasselbalch Steen G, Rinne Juha O, de Mendonça Alexandre, et al. 2016. "Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study." Brain : a journal of neurology doi:10.1093/brain/aww160
Jack Clifford R, Bennett David A, Blennow Kaj, Carrillo Maria C, Feldman Howard H, et al. 2016. "A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers." Neurology doi:10.1212/WNL.0000000000002923
Andersson Carl-Henrik, Hansson Oskar, Minthon Lennart, Andreasen Niels, Blennow Kaj, et al. 2016. "A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-160319
Zettergren Anna, Kern Silke, Gustafson Deborah, Gudmundsson Pia, Sigström Robert, et al. 2016. "The ACE Gene Is Associated with Late-Life Major Depression and Age at Dementia Onset in a Population-Based Cohort." The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry doi:10.1016/j.jagp.2016.06.009
Racine Annie M, Koscik Rebecca L, Berman Sara E, Nicholas Christopher R, Clark Lindsay R, et al. 2016. "Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife." Brain : a journal of neurology doi:10.1093/brain/aww142
Sun Xiaoyan, Dong Chuanhui, Levin Bonnie, Crocco Elizabeth, Loewenstein David, et al. 2016. "APOE ε4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association doi:10.1016/j.jalz.2016.05.003
Stanne Tara M, Åberg N David, Nilsson Staffan, Jood Katarina, Blomstrand Christian, et al. 2016. "Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke." Stroke; a journal of cerebral circulation doi:10.1161/STROKEAHA.115.012383
Kuhlmann Julia, Andreasson Ulf, Pannee Josef, Bjerke Maria, Portelius Erik, et al. 2016. "CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation." Clinica chimica acta; international journal of clinical chemistry doi:10.1016/j.cca.2016.05.014
Voevodskaya Olga, Sundgren Pia C, Strandberg Olof, Zetterberg Henrik, Minthon Lennart, et al. 2016. "Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease." Neurology 86 (19) doi:10.1212/WNL.0000000000002672
Blennow Kaj, Biscetti Leonardo, Eusebi Paolo, Parnetti Lucilla 2016. "Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice." Movement disorders : official journal of the Movement Disorder Society doi:10.1002/mds.26656
Gustavsson Carolina, Andersson Hall Ulrika, Pelanis Aurimantas, Karlsson Ove I, Andersson Louise, et al. 2016. "Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women." Obesity (Silver Spring, Md.) doi:10.1002/oby.21502
Kuhle Jens, Barro Christian, Andreasson Ulf, Derfuss Tobias, Lindberg Raija, et al. 2016. "Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa." Clinical chemistry and laboratory medicine doi:10.1515/cclm-2015-1195
Hoscheidt Siobhan M, Starks Erika J, Oh Jennifer M, Zetterberg Henrik, Blennow Kaj, et al. 2016. "Insulin Resistance is Associated with Increased Alzheimer's Disease Pathology and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-160110
Olsson Bob, Lautner Ronald, Andreasson Ulf, Öhrfelt Annika, Portelius Erik, et al. 2016. "CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis." The Lancet. Neurology doi:10.1016/S1474-4422(16)00070-3
Lehmann-Werman Roni, Neiman Daniel, Zemmour Hai, Moss Joshua, Magenheim Judith, et al. 2016. "Identification of tissue-specific cell death using methylation patterns of circulating DNA." Proceedings of the National Academy of Sciences of the United States of America 113 (13) doi:10.1073/pnas.1519286113
Kalm Marie, Andreasson Ulf, Björk-Eriksson Thomas, Zetterberg Henrik, Pekny Milos, et al. 2016. "C3 deficiency ameliorates the negative effects of irradiation of the young brain on hippocampal development and learning." Oncotarget doi:10.18632/oncotarget.8400
Novakova Lenka, Axelsson Markus, Khademi Mohsen, Zetterberg Henrik, Blennow Kaj, et al. 2016. "Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis." Multiple sclerosis (Houndmills, Basingstoke, England) doi:10.1177/1352458516639384
Oliver Jonathan M, Jones Margaret T, Kirk K Michele, Gable David A, Repshas Justin T, et al. 2016. "Serum Neurofilament Light in American Football Athletes over the Course of a Season." Journal of neurotrauma doi:10.1089/neu.2015.4295
Burman Joachim, Raininko Raili, Blennow Kaj, Zetterberg Henrik, Axelsson Markus, Malmeström Clas 2016. "YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis." Journal of neuroimmunology 292 doi:10.1016/j.jneuroim.2016.01.013
Suárez-Calvet Marc, Kleinberger Gernot, Araque Caballero Miguel Ángel, Brendel Matthias, Rominger Axel, et al. 2016. "sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers." EMBO molecular medicine doi:10.15252/emmm.201506123
Dubois Bruno, Hampel Harald, Feldman Howard H, Scheltens Philip, Aisen Paul, et al. 2016. "Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria." Alzheimer's & dementia : the journal of the Alzheimer's Association 12 (3) doi:10.1016/j.jalz.2016.02.002
Wellington Henrietta, Paterson Ross W, Portelius Erik, Törnqvist Ulrika, Magdalinou Nadia, et al. 2016. "Increased CSF neurogranin concentration is specific to Alzheimer disease." Neurology 86 (9) doi:10.1212/WNL.0000000000002423
Lelental Natalia, Brandner Sebastian, Kofanova Olga, Blennow Kaj, Zetterberg Henrik, et al. 2016. "Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-150883
Janelidze Shorena, Zetterberg Henrik, Mattsson Niklas, Palmqvist Sebastian, Vanderstichele Hugo, et al. 2016. "CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease." Annals of clinical and translational neurology 3 (3) doi:10.1002/acn3.274
Rojas Julio C, Karydas Anna, Bang Jee, Tsai Richard M, Blennow Kaj, et al. 2016. "Plasma neurofilament light chain predicts progression in progressive supranuclear palsy." Annals of clinical and translational neurology 3 (3) doi:10.1002/acn3.290
Osorio Ricardo S, Ducca Emma L, Wohlleber Margaret E, Tanzi Emily B, Gumb Tyler, et al. 2016. "Orexin-A is Associated With Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects." Sleep doi:
Scheltens Philip, Blennow Kaj, Breteler Monique M B, de Strooper Bart, Frisoni Giovanni B, et al. 2016. "Alzheimer's disease." Lancet (London, England) doi:10.1016/S0140-6736(15)01124-1
Hall Sara, Surova Yulia, Öhrfelt Annika, Blennow Kaj, Zetterberg Henrik, Hansson Oskar 2016. "Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease." Movement disorders : official journal of the Movement Disorder Society doi:10.1002/mds.26578
Duits Flora H, Martinez-Lage Pablo, Paquet Claire, Engelborghs Sebastiaan, Lleó Alberto, et al. 2016. "Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study." Alzheimer's & dementia : the journal of the Alzheimer's Association 12 (2) doi:10.1016/j.jalz.2015.08.003
Jakobsson Joel, Pålsson Erik, Sellgren Carl, Rydberg Frida, Ekman Agneta, et al. 2016. "CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder." The British journal of psychiatry : the journal of mental science 208 (2) doi:10.1192/bjp.bp.114.159806
Merisson Edyta, Mattsson Niklas, Zetterberg Henrik, Blennow Kaj, Pikwer Andreas, et al. 2016. "Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair." Neurochemistry international 93 doi:10.1016/j.neuint.2015.12.003
Evered Lisbeth, Silbert Brendan, Scott David A, Ames David, Maruff Paul, Blennow Kaj 2016. "Cerebrospinal Fluid Biomarker for Alzheimer Disease Predicts Postoperative Cognitive Dysfunction." Anesthesiology 124 (2) doi:10.1097/ALN.0000000000000953
Melah Kelsey E, Lu Sharon Yuan-Fu, Hoscheidt Siobhan M, Alexander Andrew L, Adluru Nagesh, et al. 2016. "Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease." Journal of Alzheimer's disease : JAD 50 (3) doi:10.3233/JAD-150897
Oliver Jonathan M, Jones Margaret T, Kirk K Michele, Gable David A, Repshas Justin T, et al. 2016. "Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football." Medicine and science in sports and exercise doi:10.1249/MSS.0000000000000875
Öhrfelt Annika, Axelsson Markus, Malmeström Clas, Novakova Lenka, Heslegrave Amanda, et al. 2016. "Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone." Multiple sclerosis (Houndmills, Basingstoke, England) doi:10.1177/1352458515624558
García-Ayllón María-Salud, Botella-López Arancha, Cuchillo-Ibañez Inmaculada, Rábano Alberto, Andreasen Niels, et al. 2016. "HNK-1 Carrier Glycoproteins Are Decreased in the Alzheimer's Disease Brain." Molecular neurobiology doi:10.1007/s12035-015-9644-x
Sjödin Simon, Öhrfelt Annika, Brinkmalm Gunnar, Zetterberg Henrik, Blennow Kaj, Brinkmalm Ann 2016. "Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry." Clinical proteomics 13 doi:10.1186/s12014-016-9104-2
Åberg N David, Stanne Tara M, Jood Katarina, Schiöler Linus, Blomstrand Christian, et al. 2016. "Serum erythropoietin and outcome after ischaemic stroke: a prospective study." BMJ open 6 (2) doi:10.1136/bmjopen-2015-009827
Janelidze Shorena, Hertze Joakim, Zetterberg Henrik, Landqvist Waldö Maria, Santillo Alexander, et al. 2016. "Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease." Annals of clinical and translational neurology 3 (1) doi:10.1002/acn3.266
Gisslén Magnus, Price Richard W, Andreasson Ulf, Norgren Niklas, Nilsson Staffan, et al. 2016. "Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study." EBioMedicine 3 doi:10.1016/j.ebiom.2015.11.036
Racine Annie M, Koscik Rebecca L, Nicholas Christopher R, Clark Lindsay R, Okonkwo Ozioma C, et al. 2016. "Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation." Alzheimer's & dementia (Amsterdam, Netherlands) 2 doi:10.1016/j.dadm.2015.11.006
Mattsson Niklas, Insel Philip S, Palmqvist Sebastian, Stomrud Erik, van Westen Danielle, et al. 2016. "Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis." Nature communications 7 doi:10.1038/ncomms10918
Hölttä Mikko, Dean Robert A, Siemers Eric, Mawuenyega Kwasi G, Sigurdson Wendy, et al. 2016. "A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans." Alzheimer's research & therapy 8 (1) doi:10.1186/s13195-016-0178-x
van Westen Danielle, Lindqvist Daniel, Blennow Kaj, Minthon Lennart, Nägga Katarina, et al. 2016. "Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET." Scientific reports 6 doi:10.1038/srep20709
Zetterberg Henrik, Skillbäck Tobias, Mattsson Niklas, Trojanowski John Q, Portelius Erik, et al. 2016. "Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression." JAMA neurology 73 (1) doi:10.1001/jamaneurol.2015.3037
Heslegrave Amanda, Heywood Wendy, Paterson Ross, Magdalinou Nadia, Svensson Johan, et al. 2016. "Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease." Molecular neurodegeneration 11 (1) doi:10.1186/s13024-016-0071-x
Pannee Josef, Gobom Johan, Shaw Leslie M, Korecka Magdalena, Chambers Erin E, et al. 2016. "Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry." Alzheimer's & dementia : the journal of the Alzheimer's Association 12 (1) doi:10.1016/j.jalz.2015.06.1890
Eyjolfsdottir Helga, Eriksdotter Maria, Linderoth Bengt, Lind Göran, Juliusson Bengt, et al. 2016. "Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device." Alzheimer's research & therapy 8 (1) doi:10.1186/s13195-016-0195-9
Bergström Petra, Agholme Lotta, Nazir Faisal Hayat, Satir Tugce Munise, Toombs Jamie, et al. 2016. "Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation." Scientific reports 6 doi:10.1038/srep29200
Janelidze Shorena, Stomrud Erik, Palmqvist Sebastian, Zetterberg Henrik, van Westen Danielle, et al. 2016. "Plasma β-amyloid in Alzheimer's disease and vascular disease." Scientific reports 6 doi:10.1038/srep26801
Öhrfelt Annika, Johansson Per, Wallin Anders, Andreasson Ulf, Zetterberg Henrik, et al. 2016. "Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease." Dementia and geriatric cognitive disorders extra 6 (2) doi:10.1159/000447239
Andreasson Ulf, Blennow Kaj, Zetterberg Henrik 2016. "Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders." Alzheimer's & dementia (Amsterdam, Netherlands) 3 doi:10.1016/j.dadm.2016.05.005
Cicognola Claudia, Chiasserini Davide, Eusebi Paolo, Andreasson Ulf, Vanderstichele Hugo, et al. 2016. "No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF." Molecular neurodegeneration 11 (1) doi:10.1186/s13024-016-0130-3
Degerman Gunnarsson Malin, Ingelsson Martin, Blennow Kaj, Basun Hans, Lannfelt Lars, Kilander Lena 2016. "High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease." Alzheimer's research & therapy 8 (1) doi:10.1186/s13195-016-0191-0
Skoog Ingmar, Hörder Helena, Frändin Kerstin, Johansson Lena, Östling Svante, et al. 2016. "Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years." Frontiers in aging neuroscience 8 doi:10.3389/fnagi.2016.00225

2015

Paterson Ross W, Toombs Jamie, Slattery Catherine F, Nicholas Jennifer M, Andreasson Ulf, et al. 2015. "Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis." Journal of neurology 262 (12) doi:10.1007/s00415-015-7904-3
Rosén Christoffer, Farahmand Bahman, Skillbäck Tobias, Nägga Katarina, Mattsson Niklas, et al. 2015. "Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem." Alzheimer's & dementia : the journal of the Alzheimer's Association 11 (12) doi:10.1016/j.jalz.2015.04.007
De Vos Ann, Jacobs Dirk, Struyfs Hanne, Fransen Erik, Andersson Kerstin, et al. 2015. "C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association 11 (12) doi:10.1016/j.jalz.2015.05.012
Slemmon J Randall, Shapiro Alice, Mercken Marc, Streffer Johannes, Romano Gary, et al. 2015. "Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio." Journal of neurochemistry 135 (5) doi:10.1111/jnc.13297
Shahim Pashtun, Arnell Per, Kvarnström Andreas, Rosén Anders, Bremell Daniel, et al. 2015. "Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot study." Diving and hyperbaric medicine 45 (4) doi:
Berman Sara E, Rivera-Rivera Leonardo A, Clark Lindsay R, Racine Annie M, Keevil Jon G, et al. 2015. "Intracranial Arterial 4D-Flow is Associated with Metrics of Brain Health and Alzheimer's Disease." Alzheimer's & dementia (Amsterdam, Netherlands) 1 (4) doi:10.1016/j.dadm.2015.09.005
Stomrud Erik, Minthon Lennart, Zetterberg Henrik, Blennow Kaj, Hansson Oskar 2015. "Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study." Alzheimer's & dementia (Amsterdam, Netherlands) 1 (4) doi:10.1016/j.dadm.2015.09.002
Janelidze Shorena, Lindqvist Daniel, Francardo Veronica, Hall Sara, Zetterberg Henrik, et al. 2015. "Increased CSF biomarkers of angiogenesis in Parkinson disease." Neurology 85 (21) doi:10.1212/WNL.0000000000002151
Johansson Per, Almqvist Erik G, Wallin Anders, Johansson Jan-Ove, Andreasson Ulf, et al. 2015. "Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease." Neuroscience letters 609 doi:10.1016/j.neulet.2015.10.006
Skoog Ingmar, Waern Margda, Duberstein Paul, Blennow Kaj, Zetterberg Henrik, et al. 2015. "A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden." Biological psychiatry 78 (10) doi:10.1016/j.biopsych.2015.01.006
Bittner Tobias, Zetterberg Henrik, Teunissen Charlotte E, Ostlund Richard E, Militello Michael, et al. 2015. "Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid." Alzheimer's & dementia : the journal of the Alzheimer's Association doi:10.1016/j.jalz.2015.09.009
Portelius Erik, Zetterberg Henrik, Skillbäck Tobias, Törnqvist Ulrika, Andreasson Ulf, et al. 2015. "Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease." Brain : a journal of neurology 138 (Pt 11) doi:10.1093/brain/awv267
Helmfors Linda, Boman Andrea, Civitelli Livia, Nath Sangeeta, Sandin Linnea, et al. 2015. "Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease." Neurobiology of disease 83 doi:10.1016/j.nbd.2015.08.024
Schultz Stephanie A, Boots Elizabeth A, Almeida Rodrigo P, Oh Jennifer M, Einerson Jean, et al. 2015. "Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition." Journal of the International Neuropsychological Society : JINS 21 (10) doi:10.1017/S1355617715000843
Ewers Michael, Mattsson Niklas, Minthon Lennart, Molinuevo José L, Antonell Anna, et al. 2015. "CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study." Alzheimer's & dementia : the journal of the Alzheimer's Association 11 (11) doi:10.1016/j.jalz.2014.12.006
Karami Azadeh, Eyjolfsdottir Helga, Vijayaraghavan Swetha, Lind Göran, Almqvist Per, et al. 2015. "Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association 11 (11) doi:10.1016/j.jalz.2014.11.008
Bjerke Maria, Andreasson Ulf, Kuhlmann Julia, Portelius Erik, Pannee Josef, et al. 2015. "Assessing the commutability of reference material formats for the harmonization of amyloid beta measurements." Clinical chemistry and laboratory medicine : CCLM / FESCC doi:10.1515/cclm-2015-0733
Bjerke Maria, Kern Silke, Blennow Kaj, Zetterberg Henrik, Waern Margda, et al. 2015. "Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years." Journal of Alzheimer's disease : JAD 49 (3) doi:10.3233/JAD-150525
Palmqvist Sebastian, Zetterberg Henrik, Mattsson Niklas, Johansson Per, Minthon Lennart, et al. 2015. "Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease." Neurology 85 (14) doi:10.1212/WNL.0000000000001991
Kvartsberg Hlin, Duits Flora H, Ingelsson Martin, Andreasen Niels, Öhrfelt Annika, et al. 2015. "Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association 11 (10) doi:10.1016/j.jalz.2014.10.009
Bäckström David C, Eriksson Domellöf Magdalena, Linder Jan, Olsson Bob, Öhrfelt Annika, et al. 2015. "Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease." JAMA neurology 72 (10) doi:10.1001/jamaneurol.2015.1449
Lista Simone, Molinuevo Jose L, Cavedo Enrica, Rami Lorena, Amouyel Philippe, et al. 2015. "Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline." Journal of Alzheimer's disease : JAD 48 Suppl 1 doi:10.3233/JAD-150202
Fourier Anthony, Portelius Erik, Zetterberg Henrik, Blennow Kaj, Quadrio Isabelle, Perret-Liaudet Armand 2015. "Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability." Clinica chimica acta; international journal of clinical chemistry 449 doi:10.1016/j.cca.2015.05.024
Höglund Kina, Fourier Anthony, Perret-Liaudet Armand, Zetterberg Henrik, Blennow Kaj, Portelius Erik 2015. "Alzheimer's disease--Recent biomarker developments in relation to updated diagnostic criteria." Clinica chimica acta; international journal of clinical chemistry 449 doi:10.1016/j.cca.2015.01.041
Neselius Sanna, Brisby Helena, Granholm Fredrik, Zetterberg Henrik, Blennow Kaj 2015. "Monitoring concussion in a knocked-out boxer by CSF biomarker analysis." Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 23 (9) doi:10.1007/s00167-014-3066-6
Siman Robert, Shahim Pashtun, Tegner Yelverton, Blennow Kaj, Zetterberg Henrik, Smith Douglas H 2015. "Serum SNTF Increases in Concussed Professional Ice Hockey Players and Relates to the Severity of Postconcussion Symptoms." Journal of neurotrauma 32 (17) doi:10.1089/neu.2014.3698
Kruse Niels, Persson Staffan, Alcolea Daniel, Bahl Justyna M C, Baldeiras Ines, et al. 2015. "Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study." Neurobiology of aging 36 (9) doi:10.1016/j.neurobiolaging.2015.05.003
Skillbäck Tobias, Farahmand Bahman Y, Rosén Christoffer, Mattsson Niklas, Nägga Katarina, et al. 2015. "Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia." Brain : a journal of neurology 138 (Pt 9) doi:10.1093/brain/awv181
Toledo Jon B, Zetterberg Henrik, van Harten Argonde C, Glodzik Lidia, Martinez-Lage Pablo, et al. 2015. "Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects." Brain : a journal of neurology 138 (Pt 9) doi:10.1093/brain/awv199
Tarasoff-Conway Jenna M, Carare Roxana O, Osorio Ricardo S, Glodzik Lidia, Butler Tracy, et al. 2015. "Clearance systems in the brain-implications for Alzheimer disease." Nature reviews. Neurology 11 (8) doi:10.1038/nrneurol.2015.119
Rolstad Sindre, Jakobsson Joel, Sellgren Carl, Isgren Anniella, Ekman Carl Johan, et al. 2015. "CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 25 (8) doi:10.1016/j.euroneuro.2015.04.023
Wallin Anders, Nordlund Arto, Jonsson Michael, Blennow Kaj, Zetterberg Henrik, et al. 2015. "Alzheimer's disease-subcortical vascular disease spectrum in a hospital-based setting: overview of results from the Gothenburg MCI and dementia studies." Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism doi:10.1038/jcbfm.2015.148
Wallin Anders, Nordlund Arto, Jonsson Michael, Lind Karin, Edman Åke, et al. 2015. "The Gothenburg MCI study: design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up." Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism doi:10.1038/jcbfm.2015.147
Cummings Damian M, Liu Wenfei, Portelius Erik, Bayram Sevinç, Yasvoina Marina, et al. 2015. "First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression." Brain : a journal of neurology 138 (Pt 7) doi:10.1093/brain/awv127
Jakobsson Joel, Bjerke Maria, Sahebi Sara, Isgren Anniella, Ekman Carl Johan, et al. 2015. "Monocyte and microglial activation in patients with mood-stabilized bipolar disorder." Journal of psychiatry & neuroscience : JPN 40 (4) doi:
Brinkmalm Ann, Portelius Erik, Öhrfelt Annika, Brinkmalm Gunnar, Andreasson Ulf, et al. 2015. "Explorative and targeted neuroproteomics in Alzheimer's disease." Biochimica et biophysica acta 1854 (7) doi:10.1016/j.bbapap.2015.01.009
Kang Ju-Hee, Korecka Magdalena, Figurski Michal J, Toledo Jon B, Blennow Kaj, et al. 2015. "The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans." Alzheimer's & dementia : the journal of the Alzheimer's Association 11 (7) doi:10.1016/j.jalz.2015.05.003
Jansen Willemijn J, Ossenkoppele Rik, Knol Dirk L, Tijms Betty M, Scheltens Philip, et al. 2015. "Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis." JAMA 313 (19) doi:10.1001/jama.2015.4668
Moore Steven, Evans Lewis D B, Andersson Therese, Portelius Erik, Smith James, et al. 2015. "APP metabolism regulates tau proteostasis in human cerebral cortex neurons." Cell reports 11 (5) doi:10.1016/j.celrep.2015.03.068
O'Bryant Sid E, Gupta Veer, Henriksen Kim, Edwards Melissa, Jeromin Andreas, et al. 2015. "Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research." Alzheimer's & dementia : the journal of the Alzheimer's Association 11 (5) doi:10.1016/j.jalz.2014.08.099
Blennow Kaj, Mattsson Niklas, Schöll Michael, Hansson Oskar, Zetterberg Henrik 2015. "Amyloid biomarkers in Alzheimer's disease." Trends in pharmacological sciences 36 (5) doi:10.1016/j.tips.2015.03.002
Zetterberg Henrik, Blennow Kaj 2015. "Fluid markers of traumatic brain injury." Molecular and cellular neurosciences 66 (Pt B) doi:10.1016/j.mcn.2015.02.003
Bradley Patrick, Akehurst Ron, Ballard Clive, Banerjee Sube, Blennow Kaj, et al. 2015. "Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association 11 (4) doi:10.1016/j.jalz.2014.01.007
Martínez M Alba Mañé, Olsson Bob, Bau Laura, Matas Elisabet, Cobo Calvo Álvaro, et al. 2015. "Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis." Multiple sclerosis (Houndmills, Basingstoke, England) 21 (5) doi:10.1177/1352458514549397
Bruno Davide, Grothe Michel J, Nierenberg Jay, Zetterberg Henrik, Blennow Kaj, et al. 2015. "A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals." Neuropsychologia 69 doi:10.1016/j.neuropsychologia.2015.01.025
Mattsson Niklas, Insel Philip S, Donohue Michael, Landau Susan, Jagust William J, et al. 2015. "Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease." Brain : a journal of neurology 138 (Pt 3) doi:10.1093/brain/awu367
Bruno Davide, Grothe Michel J, Nierenberg Jay, Teipel Stefan J, Zetterberg Henrik, et al. 2015. "The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals." Alzheimer's & dementia (Amsterdam, Netherlands) 1 (1) doi:10.1016/j.dadm.2014.11.002
Hölttä Mikko, Minthon Lennart, Hansson Oskar, Holmén-Larsson Jessica, Pike Ian, et al. 2015. "An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease." Journal of proteome research 14 (2) doi:10.1021/pr501076j
Wang Li-San, Naj Adam C, Graham Robert R, Crane Paul K, Kunkle Brian W, et al. 2015. "Rarity of the Alzheimer disease-protective APP A673T variant in the United States." JAMA neurology 72 (2) doi:10.1001/jamaneurol.2014.2157
Shahim Pashtun, Linemann Thomas, Inekci Dilek, Karsdal Morten Asser, Blennow Kaj, et al. 2015. "Serum tau fragments predict return to play in concussed professional ice hockey players." Journal of neurotrauma doi:10.1089/neu.2014.3741
Ferreira Daniel, Westman Eric, Eyjolfsdottir Helga, Almqvist Per, Lind Göran, et al. 2015. "Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor." Journal of Alzheimer's disease : JAD 43 (3) doi:10.3233/JAD-141068
Blennow Kaj, Dubois Bruno, Fagan Anne M, Lewczuk Piotr, de Leon Mony J, Hampel Harald 2015. "Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association 11 (1) doi:10.1016/j.jalz.2014.02.004
Thordardottir Steinunn, Ståhlbom Anne Kinhult, Ferreira Daniel, Almkvist Ove, Westman Eric, et al. 2015. "Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease." Journal of Alzheimer's disease : JAD 43 (4) doi:10.3233/JAD-140339
Kettunen Petronella, Larsson Susanna, Holmgren Sandra, Olsson Sandra, Minthon Lennart, et al. 2015. "Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function." Journal of Alzheimer's disease : JAD 44 (4) doi:10.3233/JAD-142025
Andreasson Ulf, Perret-Liaudet Armand, van Waalwijk van Doorn Linda J C, Blennow Kaj, Chiasserini Davide, et al. 2015. "A Practical Guide to Immunoassay Method Validation." Frontiers in neurology 6 doi:10.3389/fneur.2015.00179
Lista Simone, O'Bryant Sid E, Blennow Kaj, Dubois Bruno, Hugon Jacques, et al. 2015. "Biomarkers in Sporadic and Familial Alzheimer's Disease." Journal of Alzheimer's disease : JAD 47 (2) doi:10.3233/JAD-143006
Farid Karim, Carter Stephen F, Rodriguez-Vieitez Elena, Almkvist Ove, Andersen Pia, et al. 2015. "Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition." Journal of Alzheimer's disease : JAD 47 (3) doi:10.3233/JAD-141965
Bäckman Kristoffer, Joas Erik, Waern Margda, Östling Svante, Guo Xinxin, et al. 2015. "37 Years of Body Mass Index and Dementia: Effect Modification by the APOE Genotype: Observations from the Prospective Population Study of Women in Gothenburg, Sweden." Journal of Alzheimer's disease : JAD 48 (4) doi:10.3233/JAD-150326
Åberg Daniel, Johansson Per, Isgaard Jörgen, Wallin Anders, Johansson Jan-Ove, et al. 2015. "Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease." Journal of Alzheimer's disease : JAD 48 (3) doi:10.3233/JAD-150351
Travassos Maria, Santana Isabel, Baldeiras Inês, Tsolaki Magda, Gkatzima Olymbia, et al. 2015. "Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?" Journal of Alzheimer's disease : JAD 47 (4) doi:10.3233/JAD-150374
Spiegel Jonathan, Pirraglia Elizabeth, Osorio Ricardo S, Glodzik Lidia, Li Yi, et al. 2015. "Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease." Journal of Alzheimer's disease : JAD 49 (1) doi:10.3233/JAD-150167
Kvartsberg Hlin, Portelius Erik, Andreasson Ulf, Brinkmalm Gunnar, Hellwig Konstantin, et al. 2015. "Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls." Alzheimer's research & therapy 7 (1) doi:10.1186/s13195-015-0124-3
Blennow Kaj, Zetterberg Henrik 2015. "The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events." Frontiers in neuroscience 9 doi:10.3389/fnins.2015.00345
Reijs Babette L R, Teunissen Charlotte E, Goncharenko Nikolai, Betsou Fay, Blennow Kaj, et al. 2015. "The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases." Frontiers in neurology 6 doi:10.3389/fneur.2015.00216
Sjödin Simon, Andersson Kerstin K A, Mercken Marc, Zetterberg Henrik, Borghys Herman, et al. 2015. "APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment." Alzheimer's research & therapy 7 (1) doi:10.1186/s13195-015-0160-z
Hellwig Konstantin, Kvartsberg Hlin, Portelius Erik, Andreasson Ulf, Oberstein Timo Jan, et al. 2015. "Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease." Alzheimer's research & therapy 7 (1) doi:10.1186/s13195-015-0161-y
Shahim Pashtun, Mattsson Niklas, Macy Elizabeth M, Crimmins Dan L, Ladenson Jack H, et al. 2015. "Serum visinin-like protein-1 in concussed professional ice hockey players." Brain injury 29 (7-8) doi:10.3109/02699052.2015.1018324
Rolstad Sindre, Jakobsson Joel, Sellgren Carl, Ekman Carl-Johan, Blennow Kaj, et al. 2015. "Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls." PloS one 10 (5) doi:10.1371/journal.pone.0127100
Isgren Anniella, Jakobsson Joel, Pålsson Erik, Ekman Carl Johan, Johansson Anette G M, et al. 2015. "Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment." Brain, behavior, and immunity 43 doi:10.1016/j.bbi.2014.10.001
Cuchillo-Ibañez Inmaculada, Lopez-Font Inmaculada, Boix-Amorós Alba, Brinkmalm Gunnar, Blennow Kaj, et al. 2015. "Heteromers of amyloid precursor protein in cerebrospinal fluid." Molecular neurodegeneration 10 doi:10.1186/1750-1326-10-2
Lleó Alberto, Cavedo Enrica, Parnetti Lucilla, Vanderstichele Hugo, Herukka Sanna Kaisa, et al. 2015. "Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases." Nature reviews. Neurology 11 (1) doi:10.1038/nrneurol.2014.232
Portelius Erik, Lashley Tammaryn, Westerlund Anni, Persson Rita, Fox Nick C, et al. 2015. "Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry." Neuro-degenerative diseases 15 (1) doi:10.1159/000369465
Starks Erika J, Patrick O'Grady J, Hoscheidt Siobhan M, Racine Annie M, Carlsson Cynthia M, et al. 2015. "Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers." Journal of Alzheimer's disease : JAD 46 (2) doi:10.3233/JAD-150072
Masters Colin L, Bateman Randall, Blennow Kaj, Rowe Christopher C, Sperling Reisa A, Cummings Jeffrey L 2015. "Alzheimer's disease." Nature reviews. Disease primers 1 doi:10.1038/nrdp.2015.56

2014

Skillbäck Tobias, Farahmand Bahman, Bartlett Jonathan W, Rosén Christoffer, Mattsson Niklas, et al. 2014. "CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival." Neurology 83 (21) doi:10.1212/WNL.0000000000001015
Duits Flora H, Teunissen Charlotte E, Bouwman Femke H, Visser Pieter-Jelle, Mattsson Niklas, et al. 2014. "The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?" Alzheimer's & dementia : the journal of the Alzheimer's Association 10 (6) doi:10.1016/j.jalz.2013.12.023
Molinuevo José Luis, Blennow Kaj, Dubois Bruno, Engelborghs Sebastiaan, Lewczuk Piotr, et al. 2014. "The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative." Alzheimer's & dementia : the journal of the Alzheimer's Association 10 (6) doi:10.1016/j.jalz.2014.03.003
Mielke Michelle M, Haughey Norman J, Bandaru Veera V R, Zetterberg Henrik, Blennow Kaj, et al. 2014. "Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease." Neurobiology of aging 35 (11) doi:10.1016/j.neurobiolaging.2014.05.019
Brinkmalm Ann, Brinkmalm Gunnar, Honer William G, Moreno Julie A, Jakobsson Joel, et al. 2014. "Targeting synaptic pathology with a novel affinity mass spectrometry approach." Molecular & cellular proteomics : MCP 13 (10) doi:10.1074/mcp.M114.040113
Palmqvist Sebastian, Zetterberg Henrik, Blennow Kaj, Vestberg Susanna, Andreasson Ulf, et al. 2014. "Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography." JAMA neurology 71 (10) doi:10.1001/jamaneurol.2014.1358
Lautner Ronald, Palmqvist Sebastian, Mattsson Niklas, Andreasson Ulf, Wallin Anders, et al. 2014. "Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease." JAMA psychiatry 71 (10) doi:10.1001/jamapsychiatry.2014.1060
Kern Silke, Skoog Ingmar, Börjesson-Hanson Anne, Blennow Kaj, Zetterberg Henrik, et al. 2014. "Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample." Brain, behavior, and immunity 41 doi:10.1016/j.bbi.2014.05.006
Olsson Bob, Legros Laurence, Guilhot François, Strömberg Kia, Smith James, et al. 2014. "Imatinib treatment and Aβ42 in humans." Alzheimer's & dementia : the journal of the Alzheimer's Association 10 (5 Suppl) doi:10.1016/j.jalz.2013.08.283
Jakobsson Joel, Bjerke Maria, Ekman Carl Johan, Sellgren Carl, Johansson Anette G M, et al. 2014. "Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 39 (10) doi:10.1038/npp.2014.81
Bjerke Maria, Jonsson Michael, Nordlund Arto, Eckerström Carl, Blennow Kaj, et al. 2014. "Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy." Dementia and geriatric cognitive disorders extra 4 (3) doi:10.1159/000366119
Mattsson Niklas, Insel Philip S, Landau Susan, Jagust William, Donohue Michael, et al. 2014. "Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease." Annals of clinical and translational neurology 1 (8) doi:10.1002/acn3.81
Zetterberg Henrik, Jakobsson Joel, Redsäter Mikael, Andreasson Ulf, Pålsson Erik, et al. 2014. "Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment." Psychiatry research 217 (3) doi:10.1016/j.psychres.2014.03.045
Noel-Storr Anna H, McCleery Jenny M, Richard Edo, Ritchie Craig W, Flicker Leon, et al. 2014. "Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative." Neurology 83 (4) doi:10.1212/WNL.0000000000000621
Kalm Marie, Abel Edvard, Wasling Pontus, Nyman Jan, Hietala Max Albert, et al. 2014. "Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiation." International journal of radiation oncology, biology, physics 89 (3) doi:10.1016/j.ijrobp.2014.03.019
Leinenbach Andreas, Pannee Josef, Dülffer Thomas, Huber Andreas, Bittner Tobias, et al. 2014. "Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid." Clinical chemistry 60 (7) doi:10.1373/clinchem.2013.220392
Pannee Josef, Törnqvist Ulrika, Westerlund Anni, Ingelsson Martin, Lannfelt Lars, et al. 2014. "The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease." Neuroscience letters 573 doi:10.1016/j.neulet.2014.04.041
Lista Simone, Zetterberg Henrik, Dubois Bruno, Blennow Kaj, Hampel Harald 2014. "Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments." Journal of neurology 261 (6) doi:10.1007/s00415-014-7366-z
Portelius Erik, Hölttä Mikko, Soininen Hilkka, Bjerke Maria, Zetterberg Henrik, et al. 2014. "Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome." Neuromolecular medicine 16 (2) doi:10.1007/s12017-014-8302-1
Dubois Bruno, Feldman Howard H, Jacova Claudia, Hampel Harald, Molinuevo José Luis, et al. 2014. "Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria." The Lancet. Neurology 13 (6) doi:10.1016/S1474-4422(14)70090-0
Shahim Pashtun, Tegner Yelverton, Wilson David H, Randall Jeffrey, Skillbäck Tobias, et al. 2014. "Blood biomarkers for brain injury in concussed professional ice hockey players." JAMA neurology 71 (6) doi:10.1001/jamaneurol.2014.367
Osorio Ricardo S, Ayappa Indu, Mantua Janna, Gumb Tyler, Varga Andrew, et al. 2014. "Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals." Neurobiology of aging 35 (6) doi:10.1016/j.neurobiolaging.2013.12.030
Anckarsäter Rolf, Anckarsäter Henrik, Bromander Sara, Blennow Kaj, Wass Caroline, Zetterberg Henrik 2014. "Non-neurological surgery and cerebrospinal fluid biomarkers for neuronal and astroglial integrity." Journal of neural transmission (Vienna, Austria : 1996) 121 (6) doi:10.1007/s00702-013-1156-0
Alves Guido, Lange Johannes, Blennow Kaj, Zetterberg Henrik, Andreasson Ulf, et al. 2014. "CSF Aβ42 predicts early-onset dementia in Parkinson disease." Neurology 82 (20) doi:10.1212/WNL.0000000000000425
Rosén Christoffer, Andersson Carl-Henrik, Andreasson Ulf, Molinuevo José L, Bjerke Maria, et al. 2014. "Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease." Dementia and geriatric cognitive disorders extra 4 (2) doi:10.1159/000362164
Bloniecki Victor, Aarsland Dag, Cummings Jeffrey, Blennow Kaj, Freund-Levi Yvonne 2014. "Agitation in dementia: relation to core cerebrospinal fluid biomarker levels." Dementia and geriatric cognitive disorders extra 4 (2) doi:10.1159/000363500
Hampel Harald, Lista Simone, Teipel Stefan J, Garaci Francesco, Nisticò Robert, et al. 2014. "Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020." Biochemical pharmacology 88 (4) doi:10.1016/j.bcp.2013.11.009
Malmeström Clas, Axelsson Markus, Lycke Jan, Zetterberg Henrik, Blennow Kaj, Olsson Bob 2014. "CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment." Journal of neuroimmunology 269 (1-2) doi:10.1016/j.jneuroim.2014.02.004
Skillbäck Tobias, Rosén Christoffer, Asztely Fredrik, Mattsson Niklas, Blennow Kaj, Zetterberg Henrik 2014. "Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry." JAMA neurology 71 (4) doi:10.1001/jamaneurol.2013.6455
Armstrong Andrea, Mattsson Niklas, Appelqvist Hanna, Janefjord Camilla, Sandin Linnea, et al. 2014. "Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease." Neuromolecular medicine 16 (1) doi:10.1007/s12017-013-8269-3
Rosén Christoffer, Rosén Hans, Andreasson Ulf, Bremell Daniel, Bremler Rosemary, et al. 2014. "Cerebrospinal fluid biomarkers in cardiac arrest survivors." Resuscitation 85 (2) doi:10.1016/j.resuscitation.2013.10.032
Desikan Rahul S, Thompson Wesley K, Holland Dominic, Hess Christopher P, Brewer James B, et al. 2014. "The role of clusterin in amyloid-β-associated neurodegeneration." JAMA neurology 71 (2) doi:10.1001/jamaneurol.2013.4560
Salloway Stephen, Sperling Reisa, Fox Nick C, Blennow Kaj, Klunk William, et al. 2014. "Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease." The New England journal of medicine 370 (4) doi:10.1056/NEJMoa1304839
Sun Qiying, Hampel Harald, Blennow Kaj, Lista Simone, Levey Allan, et al. 2014. "Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease." Journal of Alzheimer's disease : JAD 41 (3) doi:10.3233/JAD-140177
Wesnes Keith A, Annas Peter, Basun Hans, Edgar Chris, Blennow Kaj 2014. "Performance on a pattern separation task by Alzheimer's patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels." Alzheimer's research & therapy 6 (2) doi:10.1186/alzrt250
Neselius Sanna, Brisby Helena, Marcusson Jan, Zetterberg Henrik, Blennow Kaj, Karlsson Thomas 2014. "Neurological assessment and its relationship to CSF biomarkers in amateur boxers." PloS one 9 (6) doi:10.1371/journal.pone.0099870
Trupp Miles, Jonsson Pär, Ohrfelt Annika, Zetterberg Henrik, Obudulu Ogonna, et al. 2014. "Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease." Journal of Parkinson's disease 4 (3) doi:10.3233/JPD-140389
Hjalmarsson Clara, Bjerke Maria, Andersson Björn, Blennow Kaj, Zetterberg Henrik, et al. 2014. "Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke." Journal of central nervous system disease 6 doi:10.4137/JCNSD.S13821
Hansson Oskar, Hall Sara, Ohrfelt Annika, Zetterberg Henrik, Blennow Kaj, et al. 2014. "Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease." Alzheimer's research & therapy 6 (3) doi:10.1186/alzrt255
Portelius Erik, Soininen Hilkka, Andreasson Ulf, Zetterberg Henrik, Persson Rita, et al. 2014. "Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid." Neuro-degenerative diseases 14 (2) doi:10.1159/000358800
Alcolea Daniel, Martínez-Lage Pablo, Izagirre Andrea, Clerigué Montserrat, Carmona-Iragui María, et al. 2014. "Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain." Journal of Alzheimer's disease : JAD 39 (4) doi:10.3233/JAD-131334
Bremell Daniel, Mattsson Niklas, Wallin Fredrik, Henriksson John, Wall Mariann, et al. 2014. "Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infections." Clinical biochemistry 47 (1-2) doi:10.1016/j.clinbiochem.2013.11.010
Zetterberg Henrik, Lautner Ronald, Skillbäck Tobias, Rosén Christoffer, Shahim Pashtun, et al. 2014. "CSF in Alzheimer's disease." Advances in clinical chemistry 65 doi:
Brinkmalm Ann, Brinkmalm Gunnar, Honer William G, Frölich Lutz, Hausner Lucrezia, et al. 2014. "SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease." Molecular neurodegeneration 9 doi:10.1186/1750-1326-9-53
Glodzik Lidia, Rusinek Henry, Pirraglia Elizabeth, McHugh Pauline, Tsui Wai, et al. 2014. "Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly." Neurobiology of aging 35 (1) doi:10.1016/j.neurobiolaging.2013.06.011
Portelius Erik, Dean Robert A, Andreasson Ulf, Mattsson Niklas, Westerlund Anni, et al. 2014. "β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage." Alzheimer's research & therapy 6 (5-8) doi:10.1186/s13195-014-0075-0

2013

Sala Frigerio Carlo, Lau Pierre, Salta Evgenia, Tournoy Jos, Bossers Koen, et al. 2013. "Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease." Neurology 81 (24) doi:10.1212/01.wnl.0000437306.37850.22
Olsson Bob, Constantinescu Radu, Holmberg Björn, Andreasen Niels, Blennow Kaj, Zetterberg Henrik 2013. "The glial marker YKL-40 is decreased in synucleinopathies." Movement disorders : official journal of the Movement Disorder Society doi:10.1002/mds.25589
Lista Simone, Garaci Francesco G, Ewers Michael, Teipel Stefan, Zetterberg Henrik, et al. 2013. "CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association doi:10.1016/j.jalz.2013.04.506
Henriksen Kim, O'Bryant Sid E, Hampel Harald, Trojanowski John Q, Montine Thomas J, et al. 2013. "The future of blood-based biomarkers for Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association doi:10.1016/j.jalz.2013.01.013
Marklund Niklas, Farrokhnia Nina, Hånell Anders, Vanmechelen Eugeen, Enblad Per, et al. 2013. "Monitoring of β-Amyloid Dynamics after Human Traumatic Brain Injury." Journal of neurotrauma doi:10.1089/neu.2013.2964
Shahim Pashtun, Darin Niklas, Andreasson Ulf, Blennow Kaj, Jennions Elizabeth, et al. 2013. "Cerebrospinal fluid brain injury biomarkers in children: a multicenter study." Pediatric neurology 49 (1) doi:10.1016/j.pediatrneurol.2013.02.015
Johansson Per, Almqvist Erik G, Johansson Jan-Ove, Mattsson Niklas, Hansson Oskar, et al. 2013. "Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease." Psychoneuroendocrinology 38 (7) doi:10.1016/j.psyneuen.2012.10.012
Blennow Kaj, Hampel Harald, Zetterberg Henrik 2013. "Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer's Disease." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology doi:10.1038/npp.2013.154
Braak Heiko, Zetterberg Henrik, Del Tredici Kelly, Blennow Kaj 2013. "Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid." Acta neuropathologica doi:10.1007/s00401-013-1139-0
Brinkmalm Gunnar, Brinkmalm Ann, Bourgeois Philippe, Persson Rita, Hansson Oskar, et al. 2013. "Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease." Brain research 1513 doi:10.1016/j.brainres.2013.03.019
Malmeström Clas, Gillett Alan, Jernås Margareta, Khademi Mohsen, Axelsson Markus, et al. 2013. "Serum levels of LIGHT in MS." Multiple sclerosis (Houndmills, Basingstoke, England) 19 (7) doi:10.1177/1352458512463766
Leoni Valerio, Solomon Alina, Lövgren-Sandblom Anita, Minthon Lennart, Blennow Kaj, et al. 2013. "Diagnostic Power of 24S-Hydroxycholesterol in Cerebrospinal Fluid: Candidate Marker of Brain Health." Journal of Alzheimer's disease : JAD doi:10.3233/JAD-130035
Nagy Karin, Skagervik Ina, Tumani Hayrettin, Petzold Axel, Wick Manfred, et al. 2013. "Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?" Clinical chemistry and laboratory medicine : CCLM / FESCC doi:10.1515/cclm-2012-0783
Mattsson Niklas, Andreasson Ulf, Persson Staffan, Carrillo Maria C, Collins Steven, et al. 2013. "CSF biomarker variability in the Alzheimer's Association quality control program." Alzheimer's & dementia : the journal of the Alzheimer's Association 9 (3) doi:10.1016/j.jalz.2013.01.010
Blennow Kaj, Zetterberg Henrik 2013. "The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease." The Medical clinics of North America 97 (3) doi:10.1016/j.mcna.2012.12.012
Alves Guido, Pedersen Kenn Freddy, Bloem Bastiaan R, Blennow Kaj, Zetterberg Henrik, et al. 2013. "Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease." Journal of neurology, neurosurgery, and psychiatry 84 (5) doi:10.1136/jnnp-2012-303808
Jeppsson Anna, Zetterberg Henrik, Blennow Kaj, Wikkelsø Carsten 2013. "Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers." Neurology 80 (15) doi:10.1212/WNL.0b013e31828c2fda
Kern Silke, Skoog Ingmar, Börjesson-Hanson Anne, Blennow Kaj, Zetterberg Henrik, et al. 2013. "Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years." Brain, behavior, and immunity doi:10.1016/j.bbi.2013.03.011
DeKosky Steven T, Blennow Kaj, Ikonomovic Milos D, Gandy Sam 2013. "Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers." Nature reviews. Neurology 9 (4) doi:10.1038/nrneurol.2013.36
Zetterberg Henrik, Smith Douglas H, Blennow Kaj 2013. "Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood." Nature reviews. Neurology 9 (4) doi:10.1038/nrneurol.2013.9
Krastins Bryan, Prakash Amol, Sarracino David A, Nedelkov Dobrin, Niederkofler Eric E, et al. 2013. "Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum." Clinical biochemistry 46 (6) doi:10.1016/j.clinbiochem.2012.12.019
Augutis Kristin, Axelsson Markus, Portelius Erik, Brinkmalm Gunnar, Andreasson Ulf, et al. 2013. "Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis." Multiple sclerosis (Houndmills, Basingstoke, England) 19 (5) doi:10.1177/1352458512460603
Jernås Margareta, Malmeström Clas, Axelsson Markus, Olsson Caroline, Nookaew Intawat, et al. 2013. "MS risk genes are transcriptionally regulated in CSF leukocytes at relapse." Multiple sclerosis (Houndmills, Basingstoke, England) 19 (4) doi:10.1177/1352458512455466
Vos Stephanie J B, van Rossum Ineke A, Verhey Frans, Knol Dirk L, Soininen Hilkka, et al. 2013. "Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI." Neurology 80 (12) doi:10.1212/WNL.0b013e318288690c
Handoko Maureen, Grant Marianne, Kuskowski Michael, Zahs Kathleen R, Wallin Anders, et al. 2013. "Correlation of Specific Amyloid-β Oligomers With Tau in Cerebrospinal Fluid From Cognitively Normal Older Adults." JAMA neurology doi:10.1001/jamaneurol.2013.48
Grahn Anna, Hagberg Lars, Nilsson Staffan, Blennow Kaj, Zetterberg Henrik, Studahl Marie 2013. "Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections." Journal of neurology doi:10.1007/s00415-013-6883-5
Johansson Per, Aberg Daniel, Johansson Jan-Ove, Mattsson Niklas, Hansson Oskar, et al. 2013. "Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease." Psychoneuroendocrinology doi:10.1016/j.psyneuen.2013.02.006
Dodel Richard, Rominger Axel, Bartenstein Peter, Barkhof Frederik, Blennow Kaj, et al. 2013. "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial." Lancet neurology 12 (3) doi:10.1016/S1474-4422(13)70014-0
Nutu Magdalena, Bourgeois Philippe, Zetterberg Henrik, Portelius Erik, Andreasson Ulf, et al. 2013. "Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases." Neuromolecular medicine 15 (1) doi:10.1007/s12017-012-8208-8
Jakobsson Joel, Zetterberg Henrik, Blennow Kaj, Johan Ekman Carl, Johansson Anette G M, Landén Mikael 2013. "Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 38 (4) doi:10.1038/npp.2012.231
Carrillo Maria C, Blennow Kaj, Soares Holly, Lewczuk Piotr, Mattsson Niklas, et al. 2013. "Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium." Alzheimer's & dementia : the journal of the Alzheimer's Association 9 (2) doi:10.1016/j.jalz.2012.11.003
Randall Jeffrey, Mörtberg Erik, Provuncher Gail K, Fournier David R, Duffy David C, et al. 2013. "Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study." Resuscitation 84 (3) doi:10.1016/j.resuscitation.2012.07.027
Krut Jan Jessen, Zetterberg Henrik, Blennow Kaj, Cinque Paola, Hagberg Lars, et al. 2013. "Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections." Journal of neurology 260 (2) doi:10.1007/s00415-012-6688-y
Wattmo Carina, Jedenius Erik, Blennow Kaj, Wallin Asa K 2013. "Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application." Alzheimer's research & therapy 5 (1) doi:10.1186/alzrt156
Johansson Per, Almqvist Erik G, Johansson Jan-Ove, Mattsson Niklas, Andreasson Ulf, et al. 2013. "Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease." PloS one 8 (11) doi:10.1371/journal.pone.0081989
Neselius Sanna, Zetterberg Henrik, Blennow Kaj, Marcusson Jan, Brisby Helena 2013. "Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers." PloS one 8 (11) doi:10.1371/journal.pone.0081249
Nutu Magdalena, Zetterberg Henrik, Londos Elisabet, Minthon Lennart, Nägga Katarina, et al. 2013. "Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders." Dementia and geriatric cognitive disorders 36 (1-2) doi:10.1159/000353442
Rosén Christoffer, Hansson Oskar, Blennow Kaj, Zetterberg Henrik 2013. "Fluid biomarkers in Alzheimer's disease - current concepts." Molecular neurodegeneration 8 doi:10.1186/1750-1326-8-20
Hölttä Mikko, Hansson Oskar, Andreasson Ulf, Hertze Joakim, Minthon Lennart, et al. 2013. "Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease." PloS one 8 (6) doi:10.1371/journal.pone.0066381
Neselius Sanna, Zetterberg Henrik, Blennow Kaj, Randall Jeffrey, Wilson David, et al. 2013. "Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma." Brain injury : [BI] 27 (4) doi:10.3109/02699052.2012.750752
Ragnarsson Oskar, Berglund Peter, Eder Derek N, Zetterberg Henrik, Hietala Max A, et al. 2013. "Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission." European journal of endocrinology / European Federation of Endocrine Societies 169 (2) doi:10.1530/EJE-13-0205
García-Ayllón María-Salud, Campanari María-Letizia, Brinkmalm Gunnar, Rábano Alberto, Alom Jordi, et al. 2013. "CSF Presenilin-1 complexes are increased in Alzheimer's disease." Acta neuropathologica communications 1 doi:10.1186/2051-5960-1-46
Skillbäck Tobias, Zetterberg Henrik, Blennow Kaj, Mattsson Niklas 2013. "Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples." Alzheimer's research & therapy 5 (5) doi:10.1186/alzrt212
Desikan Rahul S, Thompson Wesley K, Holland Dominic, Hess Christopher P, Brewer James B, et al. 2013. "Heart fatty acid binding protein and Aβ-associated Alzheimer's neurodegeneration." Molecular neurodegeneration 8 doi:10.1186/1750-1326-8-39
Meredith Jere E, Sankaranarayanan Sethu, Guss Valerie, Lanzetti Anthony J, Berisha Flora, et al. 2013. "Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease." PloS one 8 (10) doi:10.1371/journal.pone.0076523
Bremell Daniel, Mattsson Niklas, Edsbagge Mikael, Blennow Kaj, Andreasson Ulf, et al. 2013. "Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection." BMC neurology 13 doi:10.1186/1471-2377-13-2
Olsson Bob, Hertze Joakim, Ohlsson Mattias, Nägga Katarina, Höglund Kina, et al. 2013. "Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia." Journal of Alzheimer's disease : JAD 34 (3) doi:10.3233/JAD-121384
Daborg Jonny, Holmgren Sandra, Abramsson Alexandra, Andreasson Ulf, Zetterberg Madeleine, et al. 2013. "Complement gene single nucleotide polymorphisms and biomarker endophenotypes of Alzheimer's disease." Journal of Alzheimer's disease : JAD 35 (1) doi:10.3233/JAD-121930
Sjölander Annica, Minthon Lennart, Nuytinck Lieve, Vanmechelen Eugeen, Blennow Kaj, Nilsson Staffan 2013. "Functional mannose-binding lectin haplotype variants are associated with Alzheimer's disease." Journal of Alzheimer's disease : JAD 35 (1) doi:10.3233/JAD-122044
Zetterberg Henrik, Blennow Kaj 2013. "Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?" Journal of Alzheimer's disease : JAD 33 Suppl 1 doi:10.3233/JAD-2012-129035
Portelius Erik, Olsson Maria, Brinkmalm Gunnar, Rüetschi Ulla, Mattsson Niklas, et al. 2013. "Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease." Journal of Alzheimer's disease : JAD 33 (1) doi:10.3233/JAD-2012-120994
Olsson Bob, Hertze Joakim, Lautner Ronald, Zetterberg Henrik, Nägga Katarina, et al. 2013. "Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia." Journal of Alzheimer's disease : JAD 33 (1) doi:10.3233/JAD-2012-120787
Pannee Josef, Portelius Erik, Oppermann Madalina, Atkins Alan, Hornshaw Martin, et al. 2013. "A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's Disease patients and healthy controls." Journal of Alzheimer's disease : JAD 33 (4) doi:10.3233/JAD-2012-121471
Shahim Pashtun, Bochem Andrea E, Mattsson Niklas, Lautner Ronald, Blennow Kaj, et al. 2013. "Plasma amyloid-β in patients with Tangier disease." Journal of Alzheimer's disease : JAD 35 (2) doi:10.3233/JAD-122425

2012

Blennow Kaj, Hardy John, Zetterberg Henrik 2012. "The neuropathology and neurobiology of traumatic brain injury." Neuron 76 (5) doi:10.1016/j.neuron.2012.11.021
Mattsson Niklas, Olsson Maria, Gustavsson Mikael K, Kosicek Marko, Malnar Martina, et al. 2012. "Amyloid-β metabolism in Niemann-Pick C disease models and patients." Metabolic brain disease 27 (4) doi:10.1007/s11011-012-9332-8
Zetterberg Henrik, Blennow Kaj 2012. "Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association doi:10.1016/j.jalz.2012.07.002
Luk Connie, Compta Yaroslau, Magdalinou Nadia, Martí Maria José, Hondhamuni Geshanthi, et al. 2012. "Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies." Journal of neurochemistry 123 (3) doi:10.1111/j.1471-4159.2012.07911.x
Hall Sara, Öhrfelt Annika, Constantinescu Radu, Andreasson Ulf, Surova Yulia, et al. 2012. "Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders." Archives of neurology 69 (11) doi:10.1001/archneurol.2012.1654
Coric Vladimir, van Dyck Christopher H, Salloway Stephen, Andreasen Niels, Brody Mark, et al. 2012. "Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease." Archives of neurology 69 (11) doi:10.1001/archneurol.2012.2194
van Rossum Ineke A, Vos Stephanie J B, Burns Leah, Knol Dirk L, Scheltens Philip, et al. 2012. "Injury markers predict time to dementia in subjects with MCI and amyloid pathology." Neurology 79 (17) doi:10.1212/WNL.0b013e3182704056
Vos Stephanie, van Rossum Ineke, Burns Leah, Knol Dirk, Scheltens Philip, et al. 2012. "Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI." Neurobiology of aging 33 (10) doi:10.1016/j.neurobiolaging.2011.12.017
Wanngren Johanna, Ottervald Jan, Parpal Santiago, Portelius Erik, Strömberg Kia, et al. 2012. "Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production." The Journal of biological chemistry 287 (39) doi:10.1074/jbc.M112.376541
Naylor Mary D, Karlawish Jason H, Arnold Steven E, Khachaturian Ara S, Khachaturian Zaven S, et al. 2012. "Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit." Alzheimer's & dementia : the journal of the Alzheimer's Association 8 (5) doi:10.1016/j.jalz.2012.08.001
Blennow Kaj, Zetterberg Henrik, Fagan Anne M 2012. "Fluid biomarkers in Alzheimer disease." Cold Spring Harbor perspectives in medicine 2 (9) doi:10.1101/cshperspect.a006221
Blennow Kaj, Zetterberg Henrik, Rinne Juha O, Salloway Stephen, Wei Jenny, et al. 2012. "Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease." Archives of neurology 69 (8) doi:10.1001/archneurol.2012.90
Ewers Michael, Schmitz Susanne, Hansson Oskar, Walsh Cathal, Fitzpatrick Annette, et al. 2012. "Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease." Neurobiology of aging 33 (8) doi:10.1016/j.neurobiolaging.2011.05.005
Reinsfelt Björn, Ricksten Sven-Erik, Zetterberg Henrik, Blennow Kaj, Fredén-Lindqvist Johan, Westerlind Anne 2012. "Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery." The Annals of thoracic surgery 94 (2) doi:10.1016/j.athoracsur.2012.04.044
Bartlett Jonathan W, Frost Chris, Mattsson Niklas, Skillbäck Tobias, Blennow Kaj, et al. 2012. "Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges." Biomarkers in medicine 6 (4) doi:10.2217/bmm.12.49
Mattsson Niklas, Andreasson Ulf, Carrillo Maria C, Persson Staffan, Shaw Leslie M, et al. 2012. "Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers." Biomarkers in medicine 6 (4) doi:10.2217/bmm.12.41
Mattsson Niklas, Zegers Ingrid, Andreasson Ulf, Bjerke Maria, Blankenstein Marinus A, et al. 2012. "Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42." Biomarkers in medicine 6 (4) doi:10.2217/bmm.12.39
Kruczyk Marcin, Zetterberg Henrik, Hansson Oskar, Rolstad Sindre, Minthon Lennart, et al. 2012. "Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment." Journal of neural transmission (Vienna, Austria : 1996) 119 (7) doi:10.1007/s00702-012-0812-0
Daborg Jonny, Andreasson Ulf, Pekna Marcela, Lautner Ronald, Hanse Eric, et al. 2012. "Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease." Journal of neural transmission (Vienna, Austria : 1996) 119 (7) doi:10.1007/s00702-012-0797-8
Glodzik Lidia, Mosconi Lisa, Tsui Wai, de Santi Susan, Zinkowski Raymond, et al. 2012. "Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly." Neurobiology of aging 33 (7) doi:10.1016/j.neurobiolaging.2011.02.012
Landgren Sara, von Otter Malin, Palmér Mona Seibt, Zetterström Caroline, Nilsson Staffan, et al. 2012. "A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease." Journal of neural transmission (Vienna, Austria : 1996) 119 (7) doi:10.1007/s00702-012-0823-x
Winblad Bengt, Andreasen Niels, Minthon Lennart, Floesser Annette, Imbert Georges, et al. 2012. "Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study." Lancet neurology 11 (7) doi:10.1016/S1474-4422(12)70140-0
Skoog Ingmar, Olesen Pernille J, Blennow Kaj, Palmertz Bo, Johnson Sterling C, Bigler Erin D 2012. "Head size may modify the impact of white matter lesions on dementia." Neurobiology of aging 33 (7) doi:10.1016/j.neurobiolaging.2011.01.011
Brinkmalm Gunnar, Portelius Erik, Öhrfelt Annika, Mattsson Niklas, Persson Rita, et al. 2012. "An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid." Journal of mass spectrometry : JMS 47 (5) doi:10.1002/jms.2987
Bruno Davide, Pomara Nunzio, Nierenberg Jay, Ritchie James C, Lutz Michael W, et al. 2012. "Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants." Experimental gerontology 47 (5) doi:10.1016/j.exger.2011.09.008
Pomara Nunzio, Bruno Davide, Sarreal Antero S, Hernando Raymundo T, Nierenberg Jay, et al. 2012. "Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder." The American journal of psychiatry 169 (5) doi:
Andreasson Ulf, Portelius Erik, Pannee Josef, Zetterberg Henrik, Blennow Kaj 2012. "Multiplexing and multivariate analysis in neurodegeneration." Methods (San Diego, Calif.) 56 (4) doi:10.1016/j.ymeth.2012.02.004
Wittnam Jessica L, Portelius Erik, Zetterberg Henrik, Gustavsson Mikael K, Schilling Stephan, et al. 2012. "Pyroglutamate amyloid β (Aβ) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease." The Journal of biological chemistry 287 (11) doi:10.1074/jbc.M111.308601
Rosén Christoffer, Andreasson Ulf, Mattsson Niklas, Marcusson Jan, Minthon Lennart, et al. 2012. "Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease." Neuromolecular medicine 14 (1) doi:10.1007/s12017-012-8171-4
Jakobsson Joel, Stridsberg Mats, Zetterberg Henrik, Blennow Kaj, Ekman Carl-Johan, et al. 2012. "Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder." Journal of psychiatry & neuroscience : JPN 38 (1) doi:10.1503/jpn.120170
Movérare-Skrtic Sofia, Johansson Per, Mattsson Niklas, Hansson Oskar, Wallin Anders, et al. 2012. "Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study." Experimental gerontology 47 (2) doi:10.1016/j.exger.2011.12.005
Bredberg Anna, Gobom Johan, Almstrand Ann-Charlotte, Larsson Per, Blennow Kaj, et al. 2012. "Exhaled endogenous particles contain lung proteins." Clinical chemistry 58 (2) doi:10.1373/clinchem.2011.169235
Gustavsson Jaana, Mehlig Kirsten, Leander Karin, Strandhagen Elisabeth, Björck Lena, et al. 2012. "Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women." Atherosclerosis 220 (2) doi:10.1016/j.atherosclerosis.2011.10.011
Portelius Erik, Zetterberg Henrik, Dean Robert A, Marcil Alexandre, Bourgeois Philippe, et al. 2012. "Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease." Journal of Alzheimer's disease : JAD 31 (2) doi:10.3233/JAD-2012-120508
Mattsson Niklas, Portelius Erik, Rolstad Sindre, Gustavsson Mikael, Andreasson Ulf, et al. 2012. "Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment." Journal of Alzheimer's disease : JAD 30 (4) doi:10.3233/JAD-2012-120019
Neselius Sanna, Brisby Helena, Theodorsson Annette, Blennow Kaj, Zetterberg Henrik, Marcusson Jan 2012. "CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma." PloS one 7 (4) doi:10.1371/journal.pone.0033606
Santos Alexander Navarrete, Ewers Michael, Minthon Lennart, Simm Andreas, Silber Rolf-Edgar, et al. 2012. "Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease." Journal of Alzheimer's disease : JAD 29 (1) doi:10.3233/JAD-2012-111361
Slemmon J Randall, Meredith Jere, Guss Valerie, Andreasson Ulf, Andreasen Niels, et al. 2012. "Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects." Journal of neurochemistry 120 (2) doi:10.1111/j.1471-4159.2011.07553.x
Hansson Oskar, Stomrud Erik, Vanmechelen Eugeen, Östling Svante, Gustafson Deborah R, et al. 2012. "Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study." Journal of Alzheimer's disease : JAD 28 (1) doi:10.3233/JAD-2011-111418
Portelius Erik, Gustavsson Mikael K, Zetterberg Henrik, Andreasson Ulf, Blennow Kaj 2012. "Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient." Neuro-degenerative diseases 10 (1-4) doi:10.1159/000334537
Eriksdotter-Jönhagen Maria, Linderoth Bengt, Lind Göran, Aladellie Layth, Almkvist Ove, et al. 2012. "Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease." Dementia and geriatric cognitive disorders 33 (1) doi:10.1159/000336051
Buchhave Peder, Minthon Lennart, Zetterberg Henrik, Wallin Asa K, Blennow Kaj, Hansson Oskar 2012. "Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia." Archives of general psychiatry 69 (1) doi:10.1001/archgenpsychiatry.2011.155
Vanderstichele Hugo, Bibl Mirko, Engelborghs Sebastiaan, Le Bastard Nathalie, Lewczuk Piotr, et al. 2012. "Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative." Alzheimer's & dementia : the journal of the Alzheimer's Association 8 (1) doi:10.1016/j.jalz.2011.07.004
Fahlke Claudia, Berggren Ulf, Berglund Kristina J, Zetterberg Henrik, Blennow Kaj, et al. 2012. "Neuroendocrine assessment of serotonergic, dopaminergic, and noradrenergic functions in alcohol-dependent individuals." Alcoholism, clinical and experimental research 36 (1) doi:10.1111/j.1530-0277.2011.01598.x
Bech Sara, Hjermind Lena E, Salvesen Lisette, Nielsen Jørgen E, Heegaard Niels H H, et al. 2012. "Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes." Parkinsonism & related disorders 18 (1) doi:10.1016/j.parkreldis.2011.08.012
Pillai Anilkumar, Bruno Davide, Sarreal Antero S, Hernando Raymundo T, Saint-Louis Leslie A, et al. 2012. "Plasma BDNF levels vary in relation to body weight in females." PloS one 7 (7) doi:10.1371/journal.pone.0039358
Olsson Bob, Malmeström Clas, Basun Hans, Annas Peter, Höglund Kina, et al. 2012. "Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials." Journal of Alzheimer's disease : JAD 32 (2) doi:10.3233/JAD-2012-120931
Palmqvist Sebastian, Hertze Joakim, Minthon Lennart, Wattmo Carina, Zetterberg Henrik, et al. 2012. "Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study." PloS one 7 (6) doi:10.1371/journal.pone.0038639
Stomrud Erik, Forsberg Anton, Hägerström Douglas, Ryding Erik, Blennow Kaj, et al. 2012. "CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly." Dementia and geriatric cognitive disorders 33 (2-3) doi:10.1159/000338185
Bendlin Barbara B, Carlsson Cynthia M, Johnson Sterling C, Zetterberg Henrik, Blennow Kaj, et al. 2012. "CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease." PloS one 7 (6) doi:10.1371/journal.pone.0037720
Hölttä Mikko, Zetterberg Henrik, Mirgorodskaya Ekaterina, Mattsson Niklas, Blennow Kaj, Gobom Johan 2012. "Peptidome analysis of cerebrospinal fluid by LC-MALDI MS." PloS one 7 (8) doi:10.1371/journal.pone.0042555
Höglund Kina, Bogstedt Anna, Fabre Susanne, Aziz Ali, Annas Peter, et al. 2012. "Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease." Journal of Alzheimer's disease : JAD 32 (4) doi:10.3233/JAD-2012-120976
Mellergård Johan, Tisell Anders, Dahlqvist Leinhard Olof, Blystad Ida, Landtblom Anne-Marie, et al. 2012. "Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis." PloS one 7 (9) doi:10.1371/journal.pone.0044739
Jonsson Michael, Zetterberg Henrik, Rolstad Sindre, Edman Ake, Gouw Alida A, et al. 2012. "Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study." Dementia and geriatric cognitive disorders 34 (1) doi:10.1159/000341576
Bromander Sara, Anckarsäter Rolf, Kristiansson Marianne, Blennow Kaj, Zetterberg Henrik, et al. 2012. "Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study." Journal of neuroinflammation 9 doi:10.1186/1742-2094-9-242
Mattsson Niklas, Zetterberg Henrik, Bianconi Simona, Yanjanin Nicole M, Fu Rao, et al. 2012. "Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C." JIMD reports 3 doi:10.1007/8904_2011_47
Mattsson Niklas, Rajendran Lawrence, Zetterberg Henrik, Gustavsson Mikael, Andreasson Ulf, et al. 2012. "BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system." PloS one 7 (2) doi:10.1371/journal.pone.0031084

2011

Westman-Brinkmalm Ann, Abramsson Alexandra, Pannee Josef, Gang Chen, Gustavsson Mikael K, et al. 2011. "SILAC zebrafish for quantitative analysis of protein turnover and tissue regeneration." Journal of proteomics 75 (2) doi:10.1016/j.jprot.2011.08.008
Darreh-Shori Taher, Forsberg Anton, Modiri Negar, Andreasen Niels, Blennow Kaj, et al. 2011. "Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo." Neurobiology of aging 32 (12) doi:10.1016/j.neurobiolaging.2010.04.028
Hampel Harald, Wilcock Gordon, Andrieu Sandrine, Aisen Paul, Blennow Kaj, et al. 2011. "Biomarkers for Alzheimer's disease therapeutic trials." Progress in neurobiology 95 (4) doi:10.1016/j.pneurobio.2010.11.005
Glodzik Lidia, de Santi Susan, Tsui Wai Hon, Mosconi Lisa, Zinkowski Raymond, et al. 2011. "Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders." Neurobiology of aging 32 (12) doi:10.1016/j.neurobiolaging.2009.12.026
Olsson Bob, Zetterberg Henrik, Hampel Harald, Blennow Kaj 2011. "Biomarker-based dissection of neurodegenerative diseases." Progress in neurobiology 95 (4) doi:10.1016/j.pneurobio.2011.04.006
Ohrfelt Annika, Zetterberg Henrik, Andersson Kerstin, Persson Rita, Secic Dzemila, et al. 2011. "Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method." Neurochemical research 36 (11) doi:10.1007/s11064-011-0527-x
Desikan Rahul S, McEvoy Linda K, Thompson Wesley K, Holland Dominic, Roddey J Cooper, et al. 2011. "Amyloid-β associated volume loss occurs only in the presence of phospho-tau." Annals of neurology 70 (4) doi:10.1002/ana.22509
Hesse Camilla, Johansson Inger, Mattsson Niklas, Bremell Daniel, Andreasson Ulf, et al. 2011. "The N-terminal domain of α-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis." Biochemical and biophysical research communications 412 (3) doi:10.1016/j.bbrc.2011.07.129
Johansson Per, Johansson Jan-Ove, Labrie Fernand, Mattsson Niklas, Hansson Oskar, et al. 2011. "Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women." Clinical endocrinology 75 (3) doi:10.1111/j.1365-2265.2011.04082.x
Landgren Sara, Engel Jörgen A, Hyytiä Petri, Zetterberg Henrik, Blennow Kaj, Jerlhag Elisabet 2011. "Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference." Behavioural brain research 221 (1) doi:10.1016/j.bbr.2011.03.003
Halim Adnan, Brinkmalm Gunnar, Rüetschi Ulla, Westman-Brinkmalm Ann, Portelius Erik, et al. 2011. "Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid." Proceedings of the National Academy of Sciences of the United States of America 108 (29) doi:10.1073/pnas.1102664108
Schneider Philine, Buerger Katharina, Teipel Stefan, Uspenskaya Olga, Hartmann Oliver, et al. 2011. "Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment." Biological psychiatry 70 (2) doi:10.1016/j.biopsych.2011.01.036
Darreh-Shori Taher, Modiri Negar, Blennow Kaj, Baza Souad, Kamil Chelenk, et al. 2011. "The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase." Neurobiology of aging 32 (7) doi:10.1016/j.neurobiolaging.2009.07.015
Mattsson Niklas, Andreasson Ulf, Persson Staffan, Arai Hiroyuki, Batish Sat Dev, et al. 2011. "The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers." Alzheimer's & dementia : the journal of the Alzheimer's Association 7 (4) doi:10.1016/j.jalz.2011.05.2243
Abramsson Alexandra, Landgren Sara, Zetterberg Madeleine, Seibt Palmer Mona, Minthon Lennart, et al. 2011. "No association of LOXL1 gene polymorphisms with Alzheimer's disease." Neuromolecular medicine 13 (2) doi:10.1007/s12017-011-8144-z
Mattsson Niklas, Tabatabaei Shahrzad, Johansson Per, Hansson Oskar, Andreasson Ulf, et al. 2011. "Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility." Neuromolecular medicine 13 (2) doi:10.1007/s12017-011-8147-9
Rudolph Thiemo, Sjölander Annica, Palmér Mona Seibt, Minthon Lennart, Wallin Anders, et al. 2011. "Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts." Ophthalmic genetics 32 (2) doi:10.3109/13816810.2010.544360
Portelius Erik, Price Eric, Brinkmalm Gunnar, Stiteler Mark, Olsson Maria, et al. 2011. "A novel pathway for amyloid precursor protein processing." Neurobiology of aging 32 (6) doi:10.1016/j.neurobiolaging.2009.06.002
Pomara Nunzio, Bruno Davide, Nierenberg Jay J, Sidtis John J, Martiniuk Frank T, et al. 2011. "TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly." Neurochemical research 36 (6) doi:10.1007/s11064-011-0459-5
Shaw Leslie M, Vanderstichele Hugo, Knapik-Czajka Malgorzata, Figurski Michal, Coart Els, et al. 2011. "Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI." Acta neuropathologica 121 (5) doi:10.1007/s00401-011-0808-0
Buerger Katharina, Uspenskaya Olga, Hartmann Oliver, Hansson Oskar, Minthon Lennart, et al. 2011. "Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment." The Journal of clinical psychiatry 72 (4) doi:10.4088/JCP.09m05872oli
Ostling Svante, Gustafson Deborah, Blennow Kaj, Börjesson-Hanson Anne, Waern Margda 2011. "Psychotic symptoms in a population-based sample of 85-year-old individuals with dementia." Journal of geriatric psychiatry and neurology 24 (1) doi:10.1177/0891988710373596
Mulugeta Ezra, Londos Elisabet, Ballard Clive, Alves Guido, Zetterberg Henrik, et al. 2011. "CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies." Journal of neurology, neurosurgery, and psychiatry 82 (2) doi:10.1136/jnnp.2009.199398
Chalbot Sonia, Zetterberg Henrik, Blennow Kaj, Fladby Tormod, Andreasen Niels, et al. 2011. "Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease." Journal of Alzheimer's disease : JAD 25 (3) doi:10.3233/JAD-2011-101959
Mustafiz Tamanna, Portelius Erik, Gustavsson Mikael K, Hölttä Mikko, Zetterberg Henrik, et al. 2011. "Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice." Neuro-degenerative diseases 8 (5) doi:10.1159/000323871
Johansson Per, Mattsson Niklas, Hansson Oskar, Wallin Anders, Johansson Jan-Ove, et al. 2011. "Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population." Journal of Alzheimer's disease : JAD 24 (3) doi:10.3233/JAD-2011-101878
Bennet Anna M, Reynolds Chandra A, Eriksson Ulrika K, Hong Mun-Gwan, Blennow Kaj, et al. 2011. "Genetic association of sequence variants near AGER/NOTCH4 and dementia." Journal of Alzheimer's disease : JAD 24 (3) doi:10.3233/JAD-2011-101848
Sagare Abhay P, Deane Rashid, Zetterberg Henrik, Wallin Anders, Blennow Kaj, Zlokovic Berislav V 2011. "Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease." Journal of Alzheimer's disease : JAD 24 (1) doi:10.3233/JAD-2010-101248
Portelius Erik, Mattsson Niklas, Andreasson Ulf, Blennow Kaj, Zetterberg Henrik 2011. "Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment." Current pharmaceutical design 17 (25) doi:
Bjerke Maria, Zetterberg Henrik, Edman Åke, Blennow Kaj, Wallin Anders, Andreasson Ulf 2011. "Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease." Journal of Alzheimer's disease : JAD 27 (3) doi:10.3233/JAD-2011-110566
Ohrfelt Annika, Andreasson Ulf, Simon Adam, Zetterberg Henrik, Edman Ake, et al. 2011. "Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease." Dementia and geriatric cognitive disorders extra 1 (1) doi:10.1159/000323417
Zetterberg Henrik, Mörtberg Erik, Song Linan, Chang Lei, Provuncher Gail K, et al. 2011. "Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans." PloS one 6 (12) doi:10.1371/journal.pone.0028263
Jiang Hong, Hampel Harald, Prvulovic David, Wallin Anders, Blennow Kaj, et al. 2011. "Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease." Molecular neurodegeneration 6 doi:10.1186/1750-1326-6-69
Lautner Ronald, Mattsson Niklas, Schöll Michael, Augutis Kristin, Blennow Kaj, et al. 2011. "Biomarkers for microglial activation in Alzheimer's disease." International journal of Alzheimer's disease 2011 doi:10.4061/2011/939426
Mulugeta Ezra, Londos Elisabet, Hansson Oskar, Ballard Clive, Skogseth Ragnhild, et al. 2011. "Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates." International journal of Alzheimer's disease 2011 doi:10.4061/2011/495025
Landgren Sara, Berglund Kristina, Jerlhag Elisabet, Fahlke Claudia, Balldin Jan, et al. 2011. "Reward-related genes and personality traits in alcohol-dependent individuals: a pilot case control study." Neuropsychobiology 64 (1) doi:10.1159/000324992
Rolstad Sindre, Berg Anne Ingeborg, Bjerke Maria, Blennow Kaj, Johansson Boo, et al. 2011. "Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment." Journal of Alzheimer's disease : JAD 26 (1) doi:10.3233/JAD-2011-110038
Rosén Christoffer, Mattsson Niklas, Johansson Per M, Andreasson Ulf, Wallin Anders, et al. 2011. "Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases." Frontiers in aging neuroscience 3 doi:10.3389/fnagi.2011.00001
Dahlgren Angelica, Wargelius Hanna-Linn, Berglund Kristina J, Fahlke Claudia, Blennow Kaj, et al. 2011. "Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study." Alcohol and alcoholism (Oxford, Oxfordshire) 46 (5) doi:10.1093/alcalc/agr045
Mörtberg Erik, Zetterberg Henrik, Nordmark Johanna, Blennow Kaj, Rosengren Lars, Rubertsson Sten 2011. "S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment." Resuscitation 82 (1) doi:10.1016/j.resuscitation.2010.10.011

2010

Thorsell Annika, Bjerke Maria, Gobom Johan, Brunhage Eva, Vanmechelen Eugeen, et al. 2010. "Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease." Brain research 1362 doi:10.1016/j.brainres.2010.09.073
Mosconi Lisa, Glodzik Lidia, Mistur Rachel, McHugh Pauline, Rich Kenneth E, et al. 2010. "Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's." Biological psychiatry 68 (10) doi:10.1016/j.biopsych.2010.07.011
Blennow Kaj 2010. "Biomarkers in Alzheimer's disease drug development." Nature medicine 16 (11) doi:10.1038/nm.2221
Buchhave Peder, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, Janciauskiene Sabina, Hansson Oskar 2010. "Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment." Neurobiology of aging 31 (11) doi:10.1016/j.neurobiolaging.2008.10.012
Alves Guido, Brønnick Kolbjørn, Aarsland Dag, Blennow Kaj, Zetterberg Henrik, et al. 2010. "CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study." Journal of neurology, neurosurgery, and psychiatry 81 (10) doi:10.1136/jnnp.2009.199950
Bromander Sara, Anckarsäter Rolf, Ahrén Bo, Kristiansson Marianne, Blennow Kaj, et al. 2010. "Cerebrospinal fluid insulin during non-neurological surgery." Journal of neural transmission (Vienna, Austria : 1996) 117 (10) doi:10.1007/s00702-010-0456-x
Fjell Anders M, Walhovd Kristine B, Fennema-Notestine Christine, McEvoy Linda K, Hagler Donald J, et al. 2010. "Brain atrophy in healthy aging is related to CSF levels of Aβ1-42." Cerebral cortex (New York, N.Y. : 1991) 20 (9) doi:10.1093/cercor/bhp279
Landgren Sara, Jerlhag Elisabet, Hallman Jarmila, Oreland Lars, Lissner Lauren, et al. 2010. "Genetic variation of the ghrelin signaling system in females with severe alcohol dependence." Alcoholism, clinical and experimental research 34 (9) doi:10.1111/j.1530-0277.2010.01236.x
Constantinescu Radu, Andreasson Ulf, Li Susann, Podust Vladimir N, Mattsson Niklas, et al. 2010. "Proteomic profiling of cerebrospinal fluid in parkinsonian disorders." Parkinsonism & related disorders 16 (8) doi:10.1016/j.parkreldis.2010.06.011
Landgren Sara, Palmér Mona Seibt, Skoog Ingemar, Minthon Lennart, Wallin Anders, et al. 2010. "No association of VEGF polymorphims with Alzheimer's disease." Neuromolecular medicine 12 (3) doi:10.1007/s12017-009-8096-8
von Otter Malin, Landgren Sara, Nilsson Staffan, Lundvall Caroline, Minthon Lennart, et al. 2010. "Kinesin light chain 1 gene haplotypes in three conformational diseases." Neuromolecular medicine 12 (3) doi:10.1007/s12017-009-8103-0
Nilsson Thomas, Bromander Sara, Anckarsäter Rolf, Kristiansson Marianne, Forsman Anders, et al. 2010. "Neurochemical measures co-vary with personality traits: forensic psychiatric findings replicated in a general population sample." Psychiatry research 178 (3) doi:10.1016/j.psychres.2010.05.016
Portelius Erik, Bogdanovic Nenad, Gustavsson Mikael K, Volkmann Inga, Brinkmalm Gunnar, et al. 2010. "Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease." Acta neuropathologica 120 (2) doi:10.1007/s00401-010-0690-1
De Meyer Geert, Shapiro Fred, Vanderstichele Hugo, Vanmechelen Eugeen, Engelborghs Sebastiaan, et al. 2010. "Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people." Archives of neurology 67 (8) doi:10.1001/archneurol.2010.179
Chalbot Sonia, Zetterberg Henrik, Blennow Kaj, Fladby Tormod, Grundke-Iqbal Inge, Iqbal Khalid 2010. "Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability." Neuroscience letters 478 (3) doi:10.1016/j.neulet.2010.05.012
Hampel Harald, Frank Richard, Broich Karl, Teipel Stefan J, Katz Russell G, et al. 2010. "Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives." Nature reviews. Drug discovery 9 (7) doi:10.1038/nrd3115
Daborg Jonny, von Otter Malin, Sjölander Annica, Nilsson Staffan, Minthon Lennart, et al. 2010. "Association of the RAGE G82S polymorphism with Alzheimer's disease." Journal of neural transmission (Vienna, Austria : 1996) 117 (7) doi:10.1007/s00702-010-0437-0
Abramsson Alexandra, Westman-Brinkmalm Ann, Pannee Josef, Gustavsson Mikael, von Otter Malin, et al. 2010. "Proteomics profiling of single organs from individual adult zebrafish." Zebrafish 7 (2) doi:10.1089/zeb.2009.0644
Thorvaldsson Valgeir, Nordlund Arto, Reinvang Ivar, Blennow Kaj, Zetterberg Henrik, et al. 2010. "Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42." International psychogeriatrics / IPA 22 (4) doi:10.1017/S1041610210000335
Portelius Erik, Brinkmalm Gunnar, Tran Aijun, Andreasson Ulf, Zetterberg Henrik, et al. 2010. "Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid." Experimental neurology 223 (2) doi:10.1016/j.expneurol.2009.06.011
Hampel Harald, Shen Yong, Walsh Dominic M, Aisen Paul, Shaw Les M, et al. 2010. "Biological markers of amyloid beta-related mechanisms in Alzheimer's disease." Experimental neurology 223 (2) doi:10.1016/j.expneurol.2009.09.024
Reynolds Chandra A, Hong Mun-Gwan, Eriksson Ulrika K, Blennow Kaj, Wiklund Fredrik, et al. 2010. "Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk." Human molecular genetics 19 (10) doi:10.1093/hmg/ddq079
Mattsson Niklas, Blennow Kaj, Zetterberg Henrik 2010. "Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall." Clinical chemistry and laboratory medicine : CCLM / FESCC 48 (5) doi:10.1515/CCLM.2010.131
Trojanowski John Q, Vandeerstichele Hugo, Korecka Magdalena, Clark Christopher M, Aisen Paul S, et al. 2010. "Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects." Alzheimer's & dementia : the journal of the Alzheimer's Association 6 (3) doi:10.1016/j.jalz.2010.03.008
Gudmundsson Pia, Skoog Ingmar, Waern Margda, Blennow Kaj, Zetterberg Henrik, et al. 2010. "Is there a CSF biomarker profile related to depression in elderly women?" Psychiatry research 176 (2-3) doi:10.1016/j.psychres.2008.11.012
Rinne Juha O, Brooks David J, Rossor Martin N, Fox Nick C, Bullock Roger, et al. 2010. "11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study." Lancet neurology 9 (4) doi:10.1016/S1474-4422(10)70043-0
Sämgård Kajsa, Zetterberg Henrik, Blennow Kaj, Hansson Oskar, Minthon Lennart, Londos Elisabet 2010. "Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity." International journal of geriatric psychiatry 25 (4) doi:10.1002/gps.2353
Balldin Jan, Berggren Ulf, Berglund Kristina, Blennow Kaj, Fahlke Claudia, Zetterberg Henrik 2010. "Gamma-glutamyltransferase in alcohol use disorders: Modification of decision limits in relation to treatment goals?" Scandinavian journal of clinical and laboratory investigation 70 (2) doi:10.3109/00365510903406694
Brunnström Hans, Rawshani Nina, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, et al. 2010. "Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses." Alzheimer's & dementia : the journal of the Alzheimer's Association 6 (2) doi:10.1016/j.jalz.2009.12.005
Hansson Oskar, Zetterberg Henrik, Vanmechelen Eugeen, Vanderstichele Hugo, Andreasson Ulf, et al. 2010. "Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment." Neurobiology of aging 31 (3) doi:10.1016/j.neurobiolaging.2008.03.027
Mattsson Niklas, Sävman Karin, Osterlundh Gustaf, Blennow Kaj, Zetterberg Henrik 2010. "Converging molecular pathways in human neural development and degeneration." Neuroscience research 66 (3) doi:10.1016/j.neures.2009.11.012
Blennow Kaj, Hampel Harald, Weiner Michael, Zetterberg Henrik 2010. "Cerebrospinal fluid and plasma biomarkers in Alzheimer disease." Nature reviews. Neurology 6 (3) doi:10.1038/nrneurol.2010.4
von Otter Malin, Landgren Sara, Nilsson Staffan, Zetterberg Madeleine, Celojevic Dragana, et al. 2010. "Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract." Mechanisms of ageing and development 131 (2) doi:10.1016/j.mad.2009.12.007
Stomrud Erik, Hansson Oskar, Minthon Lennart, Blennow Kaj, Rosén Ingmar, Londos Elisabet 2010. "Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years." Neurobiology of aging 31 (2) doi:10.1016/j.neurobiolaging.2008.03.025
Reynolds Chandra A, Hong Mun-Gwan, Eriksson Ulrika K, Blennow Kaj, Johansson Boo, et al. 2010. "Sequence variation in SORL1 and dementia risk in Swedes." Neurogenetics 11 (1) doi:10.1007/s10048-009-0210-4
Stomrud Erik, Hansson Oskar, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, Londos Elisabet 2010. "Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults." Archives of neurology 67 (2) doi:10.1001/archneurol.2009.316
Zetterberg Henrik, Mattsson Niklas, Shaw Les M, Blennow Kaj 2010. "Biochemical markers in Alzheimer's disease clinical trials." Biomarkers in medicine 4 (1) doi:
Mattsson Niklas, Zetterberg Henrik, Blennow Kaj 2010. "Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease." International journal of Alzheimer's disease 2010 doi:10.4061/2010/610613
Bjerke Maria, Portelius Erik, Minthon Lennart, Wallin Anders, Anckarsäter Henrik, et al. 2010. "Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid." International journal of Alzheimer's disease 2010 doi:10.4061/2010/986310
Spitzer Philipp, Klafki Hans Wolfgang, Blennow Kaj, Buée Luc, Esselmann Hermann, et al. 2010. "cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases." International journal of Alzheimer's disease 2010 doi:10.4061/2010/548145
Zetterberg Henrik, Tullhög Kristian, Hansson Oskar, Minthon Lennart, Londos Elisabet, Blennow Kaj 2010. "Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients." European neurology 63 (6) doi:10.1159/000311703
Blennow Kaj, Zetterberg Henrik 2010. "Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?" Alzheimer's research & therapy 2 (2) doi:10.1186/alzrt31
Gustavson Christina, Wass Caroline, Mansson Jan-Eric, Blennow Kaj, Forsman Anders, et al. 2010. "Platelet monoamine oxidase B activity did not predict destructive personality traits or violent recidivism: a prospective study in male forensic psychiatric examinees." Neuropsychobiology 61 (2) doi:10.1159/000275820
von Otter Malin, Landgren Sara, Nilsson Staffan, Celojevic Dragana, Bergström Petra, et al. 2010. "Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease." BMC medical genetics 11 doi:10.1186/1471-2350-11-36
Zetterberg Madeleine, Sjölander Annica, von Otter Malin, Palmér Mona Seibt, Landgren Sara, et al. 2010. "Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease." Molecular neurodegeneration 5 doi:10.1186/1750-1326-5-11
Faux Noel G, Ritchie Craig W, Gunn Adam, Rembach Alan, Tsatsanis Andrew, et al. 2010. "PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses." Journal of Alzheimer's disease : JAD 20 (2) doi:10.3233/JAD-2010-1390
Portelius Erik, Dean Robert A, Gustavsson Mikael K, Andreasson Ulf, Zetterberg Henrik, et al. 2010. "A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease." Alzheimer's research & therapy 2 (2) doi:10.1186/alzrt30
Mattsson Niklas, Johansson Per, Hansson Oskar, Wallin Anders, Johansson Jan-Ove, et al. 2010. "Converging pathways of chromogranin and amyloid metabolism in the brain." Journal of Alzheimer's disease : JAD 20 (4) doi:10.3233/JAD-2010-091651
Rolstad Sindre, Nordlund Arto, Eckerström Carl, Gustavsson Marie H, Blennow Kaj, et al. 2010. "High education may offer protection against tauopathy in patients with mild cognitive impairment." Journal of Alzheimer's disease : JAD 21 (1) doi:10.3233/JAD-2010-091012
Andreasen Niels, Blennow Kaj, Zetterberg Henrik 2010. "Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease." International journal of Alzheimer's disease 2010 doi:10.4061/2010/638379
Gao Carol Man, Yam Alice Y, Wang Xuemei, Magdangal Erika, Salisbury Cleo, et al. 2010. "Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease." PloS one 5 (12) doi:10.1371/journal.pone.0015725
Zetterberg Henrik, Mattsson Niklas, Blennow Kaj, Olsson Bob 2010. "Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease." Alzheimer's research & therapy 2 (6) doi:10.1186/alzrt56
Bennet Anna M, Reynolds Chandra A, Gatz Margaret, Blennow Kaj, Pedersen Nancy L, Prince Jonathan A 2010. "Pleiotropy in the presence of allelic heterogeneity: alternative genetic models for the influence of APOE on serum LDL, CSF amyloid-β42, and dementia." Journal of Alzheimer's disease : JAD 22 (1) doi:10.3233/JAD-2010-100864
Sjölander Annica, Zetterberg Henrik, Andreasson Ulf, Minthon Lennart, Blennow Kaj 2010. "BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease." Molecular neurodegeneration 5 doi:10.1186/1750-1326-5-37
Selnes Per, Blennow Kaj, Zetterberg Henrik, Grambaite Ramune, Rosengren Lars, et al. 2010. "Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid." Cerebrospinal fluid research 7 doi:10.1186/1743-8454-7-10
Sundelöf Johan, Sundström Johan, Hansson Oskar, Eriksdotter-Jönhagen Maria, Giedraitis Vilmantas, et al. 2010. "Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls." Journal of Alzheimer's disease : JAD 21 (2) doi:10.3233/JAD-2010-091594
Mattsson Niklas, Bremell Daniel, Anckarsäter Rolf, Blennow Kaj, Anckarsäter Henrik, et al. 2010. "Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism." BMC neurology 10 doi:10.1186/1471-2377-10-51
Chiasserini Davide, Parnetti Lucilla, Andreasson Ulf, Zetterberg Henrik, Giannandrea David, et al. 2010. "CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease." Journal of Alzheimer's disease : JAD 22 (4) doi:10.3233/JAD-2010-101293
Sundelöf Johan, Sundström Johan, Hansson Oskar, Eriksdotter-Jönhagen Maria, Giedraitis Vilmantas, et al. 2010. "Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls." Journal of Alzheimer's disease : JAD 22 (4) doi:10.3233/JAD-2010-101023
Berggren Ulf, Fahlke Claudia, Berglund Kristina J, Wadell Kathleen, Zetterberg Henrik, et al. 2010. "Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals." Alcohol and alcoholism (Oxford, Oxfordshire) 45 (1) doi:10.1093/alcalc/agp041
Zetterberg Henrik, Blennow Kaj, Hanse Eric 2010. "Amyloid beta and APP as biomarkers for Alzheimer's disease." Experimental gerontology 45 (1) doi:10.1016/j.exger.2009.08.002
Hampel Harald, Blennow Kaj, Shaw Leslie M, Hoessler Yvonne C, Zetterberg Henrik, Trojanowski John Q 2010. "Total and phosphorylated tau protein as biological markers of Alzheimer's disease." Experimental gerontology 45 (1) doi:10.1016/j.exger.2009.10.010
Blomqvist Mia E, McCarthy Shane, Blennow Kaj, Andersson Björn, Prince Jonathan A 2010. "Evaluation of neprilysin sequence variation in relation to CSF β-Amyloid levels and Alzheimer disease risk." International journal of molecular epidemiology and genetics 1 (1) doi:
Zetterberg Henrik, Mattsson Niklas, Blennow Kaj 2010. "Cerebrospinal fluid analysis should be considered in patients with cognitive problems." International journal of Alzheimer's disease 2010 doi:10.4061/2010/163065
Hertze Joakim, Minthon Lennart, Zetterberg Henrik, Vanmechelen Eugeen, Blennow Kaj, Hansson Oskar 2010. "Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years." Journal of Alzheimer's disease : JAD 21 (4) doi:
Portelius Erik, Van Broeck Bianca, Andreasson Ulf, Gustavsson Mikael K, Mercken Marc, et al. 2010. "Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs." Journal of Alzheimer's disease : JAD 21 (3) doi:10.3233/JAD-2010-100573
Portelius Erik, Andreasson Ulf, Ringman John M, Buerger Katharina, Daborg Jonny, et al. 2010. "Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease." Molecular neurodegeneration 5 doi:10.1186/1750-1326-5-2

2009

Gavhed Désirée, Akefeldt Selma Olsson, Osterlundh Gustaf, Laurencikas Evaldas, Hjorth Lars, et al. 2009. "Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis." Pediatric blood & cancer 53 (7) doi:10.1002/pbc.22238
Landgren Sara, Engel Jörgen A, Andersson Malin E, Gonzalez-Quintela Arturo, Campos Joaquin, et al. 2009. "Association of nAChR gene haplotypes with heavy alcohol use and body mass." Brain research 1305 Suppl doi:10.1016/j.brainres.2009.08.026
Chalbot Sonia, Zetterberg Henrik, Blennow Kaj, Fladby Tormod, Grundke-Iqbal Inge, Iqbal Khalid 2009. "Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease." Clinical chemistry 55 (12) doi:10.1373/clinchem.2009.130286
Rydén Eleonore, Johansson Christian, Blennow Kaj, Landén Mikael 2009. "Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD." Journal of neural transmission (Vienna, Austria : 1996) 116 (12) doi:10.1007/s00702-009-0300-3
Mattsson Niklas, Blennow Kaj, Zetterberg Henrik 2009. "CSF biomarkers: pinpointing Alzheimer pathogenesis." Annals of the New York Academy of Sciences 1180 doi:10.1111/j.1749-6632.2009.04944.x
Philipson Ola, Hammarström Per, Nilsson K Peter R, Portelius Erik, Olofsson Tommie, et al. 2009. "A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice." Neurobiology of aging 30 (9) doi:10.1016/j.neurobiolaging.2007.11.022
Reynolds Chandra A, Hong Mun-Gwan, Eriksson Ulrika K, Blennow Kaj, Bennet Anna M, et al. 2009. "A survey of ABCA1 sequence variation confirms association with dementia." Human mutation 30 (9) doi:10.1002/humu.21076
Buerger Katharina, Frisoni Giovanni, Uspenskaya Olga, Ewers Michael, Zetterberg Henrik, et al. 2009. "Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI)." Experimental gerontology 44 (9) doi:10.1016/j.exger.2009.06.003
Zetterberg Henrik, Tanriverdi Fatih, Unluhizarci Kursad, Selcuklu Ahmet, Kelestimur Fahrettin, Blennow Kaj 2009. "Sustained release of neuron-specific enolase to serum in amateur boxers." Brain injury : [BI] 23 (9) doi:10.1080/02699050903120399
Mattsson Niklas, Zetterberg Henrik, Hansson Oskar, Andreasen Niels, Parnetti Lucilla, et al. 2009. "CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment." JAMA : the journal of the American Medical Association 302 (4) doi:10.1001/jama.2009.1064
Strozyk Dorothea, Launer Lenore J, Adlard Paul A, Cherny Robert A, Tsatsanis Andrew, et al. 2009. "Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid." Neurobiology of aging 30 (7) doi:10.1016/j.neurobiolaging.2007.10.012
Kwieciński Jakub, Kłak Marcin, Trysberg Estelle, Blennow Kaj, Tarkowski Andrej, Jin Tao 2009. "Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus." Arthritis and rheumatism 60 (7) doi:10.1002/art.24603
Visser Pieter Jelle, Verhey Frans, Knol Dirk L, Scheltens Philip, Wahlund Lars-Olof, et al. 2009. "Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study." Lancet neurology 8 (7) doi:10.1016/S1474-4422(09)70139-5
Marklund Niklas, Blennow Kaj, Zetterberg Henrik, Ronne-Engström Elisabeth, Enblad Per, Hillered Lars 2009. "Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury." Journal of neurosurgery 110 (6) doi:10.3171/2008.9.JNS08584
Brys Miroslaw, Pirraglia Elizabeth, Rich Kenneth, Rolstad Sindre, Mosconi Lisa, et al. 2009. "Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment." Neurobiology of aging 30 (5) doi:10.1016/j.neurobiolaging.2007.08.010
Glodzik-Sobanska Lidia, Pirraglia Elizabeth, Brys Miroslaw, de Santi Susan, Mosconi Lisa, et al. 2009. "The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease." Neurobiology of aging 30 (5) doi:10.1016/j.neurobiolaging.2007.08.019
Shaw Leslie M, Vanderstichele Hugo, Knapik-Czajka Malgorzata, Clark Christopher M, Aisen Paul S, et al. 2009. "Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects." Annals of neurology 65 (4) doi:10.1002/ana.21610
Sjölander Annica, Minthon Lennart, Bogdanovic Nenad, Wallin Anders, Zetterberg Henrik, Blennow Kaj 2009. "The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association." Neurobiology of aging 30 (4) doi:10.1016/j.neurobiolaging.2007.07.018
Ohrfelt Annika, Grognet Pierre, Andreasen Niels, Wallin Anders, Vanmechelen Eugeen, et al. 2009. "Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?" Neuroscience letters 450 (3) doi:10.1016/j.neulet.2008.11.015
Hansson Oskar, Buchhave Peder, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, Warkentin Siegbert 2009. "Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease." Neurobiology of aging 30 (2) doi:10.1016/j.neurobiolaging.2007.06.009
Buchhave Peder, Janciauskiene Sabina, Zetterberg Henrik, Blennow Kaj, Minthon Lennart, Hansson Oskar 2009. "Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease." Neuroscience letters 450 (1) doi:10.1016/j.neulet.2008.10.091
Wasling Pontus, Daborg Jonny, Riebe Ilse, Andersson My, Portelius Erik, et al. 2009. "Synaptic retrogenesis and amyloid-beta in Alzheimer's disease." Journal of Alzheimer's disease : JAD 16 (1) doi:10.3233/JAD-2009-0918
Kalm Marie, Fukuda Aya, Fukuda Hirotsugu, Ohrfelt Annika, Lannering Birgitta, et al. 2009. "Transient inflammation in neurogenic regions after irradiation of the developing brain." Radiation research 171 (1) doi:10.1667/RR1269.1
Portelius Erik, Brinkmalm Gunnar, Tran Ai Jun, Zetterberg Henrik, Westman-Brinkmalm Ann, Blennow Kaj 2009. "Identification of novel APP/Abeta isoforms in human cerebrospinal fluid." Neuro-degenerative diseases 6 (3) doi:10.1159/000203774
Buchhave Peder, Blennow Kaj, Zetterberg Henrik, Stomrud Erik, Londos Elisabet, et al. 2009. "Longitudinal study of CSF biomarkers in patients with Alzheimer's disease." PloS one 4 (7) doi:10.1371/journal.pone.0006294
Glodzik Lidia, De Santi Susan, Rich Kenneth E, Brys Miroslaw, Pirraglia Elizabeth, et al. 2009. "Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology." Journal of Alzheimer's disease : JAD 18 (3) doi:10.3233/JAD-2009-1183
Blennow Kaj, Zetterberg Henrik 2009. "Cerebrospinal fluid biomarkers for Alzheimer's disease." Journal of Alzheimer's disease : JAD 18 (2) doi:10.3233/JAD-2009-1177
Gerhardsson Lars, Blennow Kaj, Lundh Thomas, Londos Elisabet, Minthon Lennart 2009. "Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease." Dementia and geriatric cognitive disorders 28 (1) doi:10.1159/000233353
Brys Miroslaw, Glodzik Lidia, Mosconi Lisa, Switalski Remigiusz, De Santi Susan, et al. 2009. "Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease." Journal of Alzheimer's disease : JAD 16 (2) doi:10.3233/JAD-2009-0968
Hansson Sara F, Andréasson Ulf, Wall Mariann, Skoog Ingmar, Andreasen Niels, et al. 2009. "Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients." Journal of Alzheimer's disease : JAD 16 (2) doi:10.3233/JAD-2009-0966
Berggren Ulf, Fahlke Claudia, Berglund Kristina J, Blennow Kaj, Zetterberg Henrik, Balldin Jan 2009. "Thrombocytopenia in early alcohol withdrawal is associated with development of delirium tremens or seizures." Alcohol and alcoholism (Oxford, Oxfordshire) 44 (4) doi:10.1093/alcalc/agp012
Blom Elin S, Giedraitis Vilmantas, Zetterberg Henrik, Fukumoto Hiroaki, Blennow Kaj, et al. 2009. "Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype." Dementia and geriatric cognitive disorders 27 (5) doi:10.1159/000216841
Westman-Brinkmalm Ann, Ruetschi Ulla, Portelius Erik, Andreasson Ulf, Brinkmalm Gunnar, et al. 2009. "Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases." Frontiers in bioscience : a journal and virtual library 14 doi:
Boström Fredrik, Hansson Oskar, Blennow Kaj, Gerhardsson Lars, Lundh Thomas, et al. 2009. "Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies." Dementia and geriatric cognitive disorders 28 (4) doi:10.1159/000249145
Gisslén Magnus, Krut Jan, Andreasson Ulf, Blennow Kaj, Cinque Paola, et al. 2009. "Amyloid and tau cerebrospinal fluid biomarkers in HIV infection." BMC neurology 9 doi:10.1186/1471-2377-9-63
Bjerke Maria, Andreasson Ulf, Rolstad Sindre, Nordlund Arto, Lind Karin, et al. 2009. "Subcortical vascular dementia biomarker pattern in mild cognitive impairment." Dementia and geriatric cognitive disorders 28 (4) doi:10.1159/000252773
Portelius Erik, Zhang Bin, Gustavsson Mikael K, Brinkmalm Gunnar, Westman-Brinkmalm Ann, et al. 2009. "Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease." Neuro-degenerative diseases 6 (5-6) doi:10.1159/000264639
Sjölander Annica, Andersson Malin E, Zetterberg Henrik, Minthon Lennart, Bogdanovic Nenad, Blennow Kaj 2009. "Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk." Molecular medicine reports 2 (6) doi:10.3892/mmr_00000203

2008

Landgren Sara, Jerlhag Elisabet, Zetterberg Henrik, Gonzalez-Quintela Arturo, Campos Joaquin, et al. 2008. "Association of pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes with heavy alcohol use and body mass." Alcoholism, clinical and experimental research 32 (12) doi:10.1111/j.1530-0277.2008.00793.x
Zetterberg Henrik, Jacobsson Johan, Rosengren Lars, Blennow Kaj, Andersen Peter M 2008. "Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis." Journal of the neurological sciences 273 (1-2) doi:10.1016/j.jns.2008.06.025
Lee Jin-Moo, Blennow Kaj, Andreasen Niels, Laterza Omar, Modur Vijay, et al. 2008. "The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients." Clinical chemistry 54 (10) doi:10.1373/clinchem.2008.104497
Andersson Christin, Blennow Kaj, Almkvist Ove, Andreasen Niels, Engfeldt Peter, et al. 2008. "Increasing CSF phospho-tau levels during cognitive decline and progression to dementia." Neurobiology of aging 29 (10) doi:10.1016/j.neurobiolaging.2007.03.027
Zetterberg Madeleine, Landgren Sara, Andersson Malin E, Palmér Mona Seibt, Gustafson Deborah R, et al. 2008. "Association of complement factor H Y402H gene polymorphism with Alzheimer's disease." American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 147B (6) doi:10.1002/ajmg.b.30668
Lannfelt Lars, Blennow Kaj, Zetterberg Henrik, Batsman Stellan, Ames David, et al. 2008. "Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial." Lancet neurology 7 (9) doi:10.1016/S1474-4422(08)70167-4
Zetterberg Henrik, Andreasson Ulf, Hansson Oskar, Wu Guoxin, Sankaranarayanan Sethu, et al. 2008. "Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease." Archives of neurology 65 (8) doi:10.1001/archneur.65.8.1102
Hong Mun-Gwan, Reynolds Chandra, Gatz Margaret, Johansson Boo, Palmer Jennifer C, et al. 2008. "Evidence that the gene encoding insulin degrading enzyme influences human lifespan." Human molecular genetics 17 (15) doi:10.1093/hmg/ddn137
Nordlund Arto, Rolstad Sindre, Klang Ola, Lind Karin, Pedersen Mona, et al. 2008. "Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI." Journal of the International Neuropsychological Society : JINS 14 (4) doi:10.1017/S135561770808079X
Frisoni Giovanni B, Henneman Wouter J P, Weiner Michael W, Scheltens Philip, Vellas Bruno, et al. 2008. "The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium." Alzheimer's & dementia : the journal of the Alzheimer's Association 4 (4) doi:10.1016/j.jalz.2008.04.009
Corder Elizabeth H, Blennow Kaj, Prince Jonathan A 2008. "Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci." Rejuvenation research 11 (3) doi:10.1089/rej.2008.0742
Ewers Michael, Zhong Zhenyu, Bürger Katharina, Wallin Anders, Blennow Kaj, et al. 2008. "Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease." Brain : a journal of neurology 131 (Pt 5) doi:10.1093/brain/awn034
Portelius Erik, Hansson Sara F, Tran Ai Jun, Zetterberg Henrik, Grognet Pierre, et al. 2008. "Characterization of tau in cerebrospinal fluid using mass spectrometry." Journal of proteome research 7 (5) doi:10.1021/pr7008669
Kadir Ahmadul, Andreasen Niels, Almkvist Ove, Wall Anders, Forsberg Anton, et al. 2008. "Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease." Annals of neurology 63 (5) doi:10.1002/ana.21345
Klyubin Igor, Betts Vicki, Welzel Alfred T, Blennow Kaj, Zetterberg Henrik, et al. 2008. "Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization." The Journal of neuroscience : the official journal of the Society for Neuroscience 28 (16) doi:10.1523/JNEUROSCI.5161-07.2008
Portelius Erik, Zetterberg Henrik, Gobom Johan, Andreasson Ulf, Blennow Kaj 2008. "Targeted proteomics in Alzheimer's disease: focus on amyloid-beta." Expert review of proteomics 5 (2) doi:10.1586/14789450.5.2.225
Buchhave Peder, Stomrud Erik, Warkentin Siegbert, Blennow Kaj, Minthon Lennart, Hansson Oskar 2008. "Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease." Dementia and geriatric cognitive disorders 25 (6) doi:10.1159/000137379
Hampel Harald, Bürger Katharina, Teipel Stefan J, Bokde Arun L W, Zetterberg Henrik, Blennow Kaj 2008. "Core candidate neurochemical and imaging biomarkers of Alzheimer's disease." Alzheimer's & dementia : the journal of the Alzheimer's Association 4 (1) doi:10.1016/j.jalz.2007.08.006
Tullberg Mats, Blennow Kaj, Månsson Jan-Eric, Fredman Pam, Tisell Magnus, Wikkelsö Carsten 2008. "Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus." Cerebrospinal fluid research 5 doi:10.1186/1743-8454-5-9
Mattsson Niklas, Rüetschi Ulla, Pijnenburg Yolande A L, Blankenstein Marinus A, Podust Vladimir N, et al. 2008. "Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia." Molecular medicine reports 1 (5) doi:10.3892/mmr_00000025

2007

Mattsson Niklas, Rüetschi Ulla, Podust Vladimir N, Stridsberg Mats, Li Susann, et al. 2007. "Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis." Journal of neurochemistry 103 (5) doi:10.1111/j.1471-4159.2007.04985.x
Zetterberg Henrik, Pedersen Mona, Lind Karin, Svensson Maria, Rolstad Sindre, et al. 2007. "Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years." Journal of Alzheimer's disease : JAD 12 (3) doi:
Ray Sandip, Britschgi Markus, Herbert Charles, Takeda-Uchimura Yoshiko, Boxer Adam, et al. 2007. "Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins." Nature medicine 13 (11) doi:10.1038/nm1653
Portelius Erik, Tran Ai Jun, Andreasson Ulf, Persson Rita, Brinkmalm Gunnar, et al. 2007. "Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry." Journal of proteome research 6 (11) doi:10.1021/pr0703627
Gudmundsson Pia, Skoog Ingmar, Waern Margda, Blennow Kaj, Pálsson Sigurdur, et al. 2007. "The relationship between cerebrospinal fluid biomarkers and depression in elderly women." The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 15 (10) doi:10.1097/JGP.0b013e3180547091
Zetterberg Henrik, Jonsson Michael, Rasulzada Abdullah, Popa Cornel, Styrud Ewa, et al. 2007. "No neurochemical evidence for brain injury caused by heading in soccer." British journal of sports medicine 41 (9) doi:10.1136/bjsm.2007.037143
Hansson Sara F, Simonsen Anja Hviid, Zetterberg Henrik, Andersen Oluf, Haghighi Sara, et al. 2007. "Cystatin C in cerebrospinal fluid and multiple sclerosis." Annals of neurology 62 (2) doi:10.1002/ana.20945
Andersson Malin E, Sjölander Annica, Andreasen Niels, Minthon Lennart, Hansson Oskar, et al. 2007. "Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease." International journal of molecular medicine 20 (2) doi:
García-Ayllón María-Salud, Silveyra María-Ximena, Andreasen Niels, Brimijoin Stephen, Blennow Kaj, Sáez-Valero Javier 2007. "Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease." Journal of neurochemistry 101 (6) doi:10.1111/j.1471-4159.2007.04461.x
Andreasson Ulf, Portelius Erik, Andersson Malin E, Blennow Kaj, Zetterberg Henrik 2007. "Aspects of beta-amyloid as a biomarker for Alzheimer's disease." Biomarkers in medicine 1 (1) doi:10.2217/17520363.1.1.59
Zetterberg Madeleine, Tasa Gunnar, Palmér Mona Seibt, Juronen Erkki, Toover Egle, et al. 2007. "Methylenetetrahydrofolate reductase genetic polymorphisms in patients with primary open-angle glaucoma." Ophthalmic genetics 28 (2) doi:10.1080/13816810701329046
Zetterberg Madeleine, Tasa Gunnar, Palmér Mona Seibt, Juronen Erkki, Teesalu Pait, et al. 2007. "Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma." American journal of ophthalmology 143 (6) doi:10.1016/j.ajo.2007.01.031
Zhong Zhenyu, Ewers Michael, Teipel Stefan, Bürger Katharina, Wallin Anders, et al. 2007. "Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment." Archives of general psychiatry 64 (6) doi:10.1001/archpsyc.64.6.718
Blennow Kaj, Zetterberg Henrik, Minthon Lennart, Lannfelt Lars, Strid Stig, et al. 2007. "Longitudinal stability of CSF biomarkers in Alzheimer's disease." Neuroscience letters 419 (1) doi:10.1016/j.neulet.2007.03.064
Yamamori Hidenaga, Khatoon Sabiha, Grundke-Iqbal Inge, Blennow Kaj, Ewers Michael, et al. 2007. "Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification." Neuroscience letters 418 (2) doi:10.1016/j.neulet.2007.03.022
Nylén Karin, Csajbok Ludwig Z, Ost Martin, Rashid Anas, Blennow Kaj, et al. 2007. "Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage." Stroke; a journal of cerebral circulation 38 (5) doi:10.1161/STROKEAHA.106.478362
Gustafson Deborah R, Skoog Ingmar, Rosengren Lars, Zetterberg Henrik, Blennow Kaj 2007. "Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women." Journal of neurology, neurosurgery, and psychiatry 78 (5) doi:10.1136/jnnp.2006.100529
Mattsson Niklas, Haghighi Sara, Andersen Oluf, Yao Yuemang, Rosengren Lars, et al. 2007. "Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients." Neuroscience letters 414 (3) doi:10.1016/j.neulet.2006.12.044
Simonsen Anja H, McGuire James, Hansson Oskar, Zetterberg Henrik, Podust Vladimir N, et al. 2007. "Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment." Archives of neurology 64 (3) doi:10.1001/archneur.64.3.366
Hansson Oskar, Zetterberg Henrik, Buchhave Peder, Andreasson Ulf, Londos Elisabet, et al. 2007. "Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment." Dementia and geriatric cognitive disorders 23 (5) doi:10.1159/000100926
Andersson Christin, Blennow Kaj, Johansson Sven-Erik, Almkvist Ove, Engfeldt Peter, et al. 2007. "Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment." Dementia and geriatric cognitive disorders 23 (2) doi:10.1159/000097354
Thorsell Annika, Portelius Erik, Blennow Kaj, Westman-Brinkmalm Ann 2007. "Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment." Rapid communications in mass spectrometry : RCM 21 (5) doi:10.1002/rcm.2898
Andersson Malin E, Zetterberg Madeleine, Tasa Gunnar, Seibt-Palmér Mona, Juronen Erkki, et al. 2007. "Variability in the kinesin light chain 1 gene may influence risk of age-related cataract." Molecular vision 13 doi:
Höglund Kina, Blennow Kaj 2007. "Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease." CNS drugs 21 (6) doi:
Berggren Ulf, Eriksson Matts, Fahlke Claudia, Blennow Kaj, Balldin Jan 2007. "Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects." Alcohol and alcoholism (Oxford, Oxfordshire) 42 (3) doi:10.1093/alcalc/agm031
Englund Hillevi, Annerén Göran, Gustafsson Jan, Wester Ulrika, Wiltfang Jens, et al. 2007. "Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome." Dementia and geriatric cognitive disorders 24 (5) doi:10.1159/000109215
Stomrud Erik, Hansson Oskar, Blennow Kaj, Minthon Lennart, Londos Elisabet 2007. "Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly." Dementia and geriatric cognitive disorders 24 (2) doi:10.1159/000105017
Anckarsäter Rolf, Zetterberg Henrik, Blennow Kaj, Anckarsäter Henrik 2007. "Association between thyroid hormone levels and monoaminergic neurotransmission during surgery." Psychoneuroendocrinology 32 (8-10) doi:10.1016/j.psyneuen.2007.07.007

2006

Portelius Erik, Zetterberg Henrik, Andreasson Ulf, Brinkmalm Gunnar, Andreasen Niels, et al. 2006. "An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid." Neuroscience letters 409 (3) doi:10.1016/j.neulet.2006.09.044
Zetterberg Henrik, Hietala M Albert, Jonsson Michael, Andreasen Niels, Styrud Ewa, et al. 2006. "Neurochemical aftermath of amateur boxing." Archives of neurology 63 (9) doi:10.1001/archneur.63.9.1277
Merrill Charley A, Jonsson Michael A G, Minthon Lennart, Ejnell Hasse, C-son Silander Hans, et al. 2006. "Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year." The Journal of clinical psychiatry 67 (8) doi:
Blennow Kaj, de Leon Mony J, Zetterberg Henrik 2006. "Alzheimer's disease." Lancet 368 (9533) doi:10.1016/S0140-6736(06)69113-7
Nilselid A-M, Davidsson Pia, Nägga Katarina, Andreasen Niels, Fredman Pam, Blennow Kaj 2006. "Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms." Neurochemistry international 48 (8) doi:10.1016/j.neuint.2005.12.005
Riemenschneider Matthias, Blennow Kaj, Wagenpfeil Stefan, Andreasen Niels, Prince Jonathan A, et al. 2006. "The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease." Human mutation 27 (6) doi:10.1002/humu.20326
Portelius Erik, Westman-Brinkmalm Ann, Zetterberg Henrik, Blennow Kaj 2006. "Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry." Journal of proteome research 5 (4) doi:10.1021/pr050475v
Hansson Oskar, Zetterberg Henrik, Buchhave Peder, Londos Elisabet, Blennow Kaj, Minthon Lennart 2006. "Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study." Lancet neurology 5 (3) doi:10.1016/S1474-4422(06)70355-6
Blomqvist Mia E-L, Reynolds Chandra, Katzov Hagit, Feuk Lars, Andreasen Niels, et al. 2006. "Towards compendia of negative genetic association studies: an example for Alzheimer disease." Human genetics 119 (1-2) doi:10.1007/s00439-005-0078-9
Vanderstichele Hugo, De Vreese Karen, Blennow Kaj, Andreasen Niels, Sindic Christian, et al. 2006. "Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies." Clinical chemistry and laboratory medicine : CCLM / FESCC 44 (12) doi:10.1515/CCLM.2006.258
Mielke Michelle M, Zandi Peter P, Blennow Kaj, Gustafson Deborah, Sjögren Magnus, et al. 2006. "Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life." Alzheimer disease and associated disorders 20 (1) doi:10.1097/01.wad.0000201848.67954.7d
Andersson Lars-Magnus, Hagberg Lars, Rosengren Lars, Fuchs Dietmar, Blennow Kaj, Gisslén Magnus 2006. "Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report." BMC infectious diseases 6 doi:10.1186/1471-2334-6-141
Berggren Ulf, Fahlke Claudia, Aronsson Erik, Karanti Aikaterini, Eriksson Matts, et al. 2006. "The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small." Alcohol and alcoholism (Oxford, Oxfordshire) 41 (5) doi:10.1093/alcalc/agl043
Buerger Katharina, Otto Markus, Teipel Stefan J, Zinkowski Raymond, Blennow Kaj, et al. 2006. "Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease." Neurobiology of aging 27 (1) doi:10.1016/j.neurobiolaging.2004.12.003
Katzov Hagit, Bennet Anna M, Höglund Kina, Wiman Björn, Lütjohann Dieter, et al. 2006. "Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels." Journal of human genetics 51 (3) doi:10.1007/s10038-005-0341-x

2005

Buerger Katharina, Teipel Stefan J, Zinkowski Raymond, Sunderland Trey, Andreasen Niels, et al. 2005. "Increased levels of CSF phosphorylated tau in apolipoprotein E epsilon4 carriers with mild cognitive impairment." Neuroscience letters 391 (1-2) doi:10.1016/j.neulet.2005.08.030
Wahlund Lars-Olof, Almkvist Ove, Blennow Kaj, Engedahl Knut, Johansson Aki, et al. 2005. "Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup." Topics in magnetic resonance imaging : TMRI 16 (6) doi:10.1097/01.rmr.0000245463.36148.12
Blennow Kaj, Johansson Annica, Zetterberg Henrik 2005. "Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease." International journal of molecular medicine 16 (6) doi:
Rüetschi Ulla, Zetterberg Henrik, Podust Vladimir N, Gottfries Johan, Li Susann, et al. 2005. "Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF." Experimental neurology 196 (2) doi:10.1016/j.expneurol.2005.08.002
Zetterberg Madeleine, Tasa Gunnar, Prince Jonathan A, Palmér Mona, Juronen Erkki, et al. 2005. "Methylenetetrahydrofolate reductase genetic polymorphisms in patients with cataract." American journal of ophthalmology 140 (5) doi:10.1016/j.ajo.2005.05.026
Iqbal Khalid, Flory Michael, Khatoon Sabiha, Soininen Hilkka, Pirttila Tuula, et al. 2005. "Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers." Annals of neurology 58 (5) doi:10.1002/ana.20639
Vanderstichele Hugo, De Meyer Geert, Andreasen Niels, Kostanjevecki Vesna, Wallin Anders, et al. 2005. "Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment." Clinical chemistry 51 (9) doi:10.1373/clinchem.2005.051201
Blennow Kaj 2005. "CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment." Expert review of molecular diagnostics 5 (5) doi:10.1586/14737159.5.5.661
Höglund Kina, Syversen Steinar, Lewczuk Piotr, Wallin Anders, Wiltfang Jens, Blennow Kaj 2005. "Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease." Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 164 (2) doi:10.1007/s00221-005-2243-8
Blomqvist Mia E-L, Chalmers Katy, Andreasen Niels, Bogdanovic Nenad, Wilcock Gordon K, et al. 2005. "Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain." Neurobiology of aging 26 (6) doi:10.1016/j.neurobiolaging.2004.07.011
Andreasen Niels, Blennow Kaj 2005. "CSF biomarkers for mild cognitive impairment and early Alzheimer's disease." Clinical neurology and neurosurgery 107 (3) doi:10.1016/j.clineuro.2004.10.011
Olsson Annika, Vanderstichele Hugo, Andreasen Niels, De Meyer Geert, Wallin Anders, et al. 2005. "Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology." Clinical chemistry 51 (2) doi:10.1373/clinchem.2004.039347
Molander-Melin Marie, Blennow Kaj, Bogdanovic Nenad, Dellheden Birgitta, Månsson Jan-Eric, Fredman Pam 2005. "Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains." Journal of neurochemistry 92 (1) doi:10.1111/j.1471-4159.2004.02849.x
Johansson Annica, Zetterberg Henrik, Håkansson Anna, Nissbrandt Hans, Blennow Kaj 2005. "TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease." Neuro-degenerative diseases 2 (1) doi:10.1159/000086428
Zetterberg Henrik, Hammarin Anna-Lena, Nilsson Petra, Andersson Elsa, Lind Börje, Blennow Kaj 2005. "[New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis]." Läkartidningen 102 (12-13) doi:
Nagga Katarina, Garcia Jorge, Zetterberg Henrik, Blennow Kaj, Gottfries Johan, Marcusson Jan 2005. "Evaluation of factors of importance for clinical dementia diagnosis." Dementia and geriatric cognitive disorders 19 (5-6) doi:10.1159/000084554
Westman-Brinkmalm Ann, Karlsson Gösta, Brive Lena M, Hedberg-Fogel Kristina, Persson Rita, et al. 2005. "Analysis of proteins from a glioma cell line by using micro-scale solution isoelectric focusing in combination with liquid chromatography/tandem mass spectrometry." Rapid communications in mass spectrometry : RCM 19 (24) doi:10.1002/rcm.2237
Sjögren Magnus, Blennow Kaj 2005. "The link between cholesterol and Alzheimer's disease." The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 6 (2) doi:
Blennow Kaj, Popa Cornel, Rasulzada Abdullah, Minthon Lennart, Wallin Anders, Zetterberg Henrik 2005. "[There is a strong evidence that professional boxing results in chronic brain damage. The more head punches during a boxer's career, the bigger is the risk]." Läkartidningen 102 (36) doi:
Johansson Annica, Zetterberg Henrik, Hampel Harald, Buerger Katharina, Prince Jonathan A, et al. 2005. "Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease." Dementia and geriatric cognitive disorders 20 (6) doi:10.1159/000088634

2004

Hampel Harald, Blennow Kaj 2004. "CSF tau and β-amyloid as biomarkers for mild cognitive impairment." Dialogues in clinical neuroscience 6 (4) doi:
Strandhagen Elisabeth, Zetterberg Henrik, Aires Nibia, Palmér Mona, Rymo Lars, et al. 2004. "The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee." Lipids in health and disease 3 doi:10.1186/1476-511X-3-26
Paulson Linda, Martin Peter, Ljung Elisabeth, Blennow Kaj, Davidsson Pia 2004. "Effects on rat thalamic proteome by acute and subchronic MK-801-treatment." European journal of pharmacology 505 (1-3) doi:10.1016/j.ejphar.2004.10.036
Hansson Sara Folkesson, Puchades Maja, Blennow Kaj, Sjögren Magnus, Davidsson Pia 2004. "Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients." Proteome science 2 (1) doi:10.1186/1477-5956-2-7
Katzov Hagit, Bennet Anna M, Kehoe Patrick, Wiman Björn, Gatz Margaret, et al. 2004. "A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity." Human molecular genetics 13 (21) doi:10.1093/hmg/ddh286
Zetterberg Henrik, Andreasen Niels, Blennow Kaj 2004. "Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease." Neuroscience letters 367 (2) doi:10.1016/j.neulet.2004.06.001
Ryberg Henrik, Söderling Ann-Sofi, Davidsson Pia, Blennow Kaj, Caidahl Kenneth, Persson Lennart I 2004. "Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease." Neurochemistry international 45 (1) doi:10.1016/j.neuint.2003.12.012
Schmitt Andrea, Wilczek Katrin, Blennow Kaj, Maras Athanasios, Jatzko Alexander, et al. 2004. "Altered thalamic membrane phospholipids in schizophrenia: a postmortem study." Biological psychiatry 56 (1) doi:10.1016/j.biopsych.2004.03.019
Olsson Annika, Csajbok Ludvig, Ost Martin, Höglund Kina, Nylén Karin, et al. 2004. "Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury." Journal of neurology 251 (7) doi:10.1007/s00415-004-0451-y
Blomqvist Mia E-L, Silburn Peter A, Buchanan Daniel D, Andreasen Niels, Blennow Kaj, et al. 2004. "Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease." Neurogenetics 5 (2) doi:10.1007/s10048-004-0173-4
Strandhagen Elisabeth, Zetterberg Henrik, Aires Nibia, Palmér Mona, Rymo Lars, et al. 2004. "The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study." International journal of molecular medicine 13 (6) doi:
Johansson Annica, Katzov Hagit, Zetterberg Henrik, Feuk Lars, Johansson Boo, et al. 2004. "Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease." Human genetics 114 (6) doi:10.1007/s00439-004-1107-9
Blennow Kaj 2004. "Cerebrospinal fluid protein biomarkers for Alzheimer's disease." NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 1 (2) doi:10.1602/neurorx.1.2.213
Kehoe Patrick G, Katzov Hagit, Andreasen Niels, Gatz Maragaret, Wilcock Gordon K, et al. 2004. "Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease." Human genetics 114 (5) doi:10.1007/s00439-004-1093-y
Katzov Hagit, Chalmers Katy, Palmgren Juni, Andreasen Niels, Johansson Boo, et al. 2004. "Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism." Human mutation 23 (4) doi:10.1002/humu.20012
Blomqvist Mia E-L, Andreasen Niels, Bogdanovic Nenad, Blennow Kaj, Brookes Anthony J, Prince Jonathan A 2004. "Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease." Neuroscience letters 358 (3) doi:10.1016/j.neulet.2004.01.032
Paulson Linda, Martin Peter, Nilsson Carol L, Ljung Elisabeth, Westman-Brinkmalm Ann, et al. 2004. "Comparative proteome analysis of thalamus in MK-801-treated rats." Proteomics 4 (3) doi:10.1002/pmic.200300622
Höglund Kina, Wiklund Olov, Vanderstichele Hugo, Eikenberg Oliver, Vanmechelen Eugeen, Blennow Kaj 2004. "Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins." Archives of neurology 61 (3) doi:10.1001/archneur.61.3.333
Diamandis Eleftherios P, Scorilas Andreas, Kishi Tadaaki, Blennow Kaj, Luo Liu-Ying, et al. 2004. "Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia." Clinical biochemistry 37 (3) doi:10.1016/j.clinbiochem.2003.11.012
Trysberg Estelle, Blennow Kaj, Zachrisson Olof, Tarkowski Andrej 2004. "Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement." Arthritis research & therapy 6 (6) doi:10.1186/ar1228
Trysberg Estelle, Höglund Kina, Svenungsson Elisabet, Blennow Kaj, Tarkowski Andrej 2004. "Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus." Arthritis research & therapy 6 (2) doi:10.1186/ar1040
McCaddon Andrew, Blennow Kaj, Hudson Peter, Hughes Alan, Barber Joan, et al. 2004. "Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's disease." Dementia and geriatric cognitive disorders 17 (3) doi:10.1159/000076359
Hampel Harald, Buerger Katharina, Zinkowski Raymond, Teipel Stefan J, Goernitz Alexander, et al. 2004. "Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study." Archives of general psychiatry 61 (1) doi:10.1001/archpsyc.61.1.95

2003

Zetterberg Henrik, Wahlund Lars-Olof, Blennow Kaj 2003. "Cerebrospinal fluid markers for prediction of Alzheimer's disease." Neuroscience letters 352 (1) doi:
Prince Jonathan A, Feuk Lars, Gu Harvest F, Johansson Boo, Gatz Margaret, et al. 2003. "Genetic variation in a haplotype block spanning IDE influences Alzheimer disease." Human mutation 22 (5) doi:10.1002/humu.10282
Puchades Maja, Hansson Sara Folkesson, Nilsson Carol L, Andreasen Niels, Blennow Kaj, Davidsson Pia 2003. "Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease." Brain research. Molecular brain research 118 (1-2) doi:
Johansson Anders, Larsson Anders, Nygren Ingela, Blennow Kaj, Askmark Håkan 2003. "Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis." Neuroreport 14 (14) doi:10.1097/01.wnr.0000093756.78398.f0
Andreasen Niels, Sjögren Magnus, Blennow Kaj 2003. "CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42." The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 4 (4) doi:
Blennow Kaj, Hampel Harald 2003. "CSF markers for incipient Alzheimer's disease." Lancet neurology 2 (10) doi:
Zetterberg Henrik, Zafiropoulos Alexis, Spandidos Demetrios A, Rymo Lars, Blennow Kaj 2003. "Gene-gene interaction between fetal MTHFR 677C>T and transcobalamin 776C>G polymorphisms in human spontaneous abortion." Human reproduction (Oxford, England) 18 (9) doi:
Olsson Annika, Höglund Kina, Sjögren Magnus, Andreasen Niels, Minthon Lennart, et al. 2003. "Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients." Experimental neurology 183 (1) doi:
Blennow Kaj, Vanmechelen Eugeen 2003. "CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry." Brain research bulletin 61 (3) doi:
Tarkowski Elisabeth, Liljeroth Ann Marie, Minthon Lennart, Tarkowski Andrzej, Wallin Anders, Blennow Kaj 2003. "Cerebral pattern of pro- and anti-inflammatory cytokines in dementias." Brain research bulletin 61 (3) doi:
Gustafson Deborah, Rothenberg Elisabet, Blennow Kaj, Steen Bertil, Skoog Ingmar 2003. "An 18-year follow-up of overweight and risk of Alzheimer disease." Archives of internal medicine 163 (13) doi:10.1001/archinte.163.13.1524
Sjögren Magnus, Andreasen Niels, Blennow Kaj 2003. "Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers." Clinica chimica acta; international journal of clinical chemistry 332 (1-2) doi:
Kehoe Patrick G, Katzov Hagit, Feuk Lars, Bennet Anna M, Johansson Boo, et al. 2003. "Haplotypes extending across ACE are associated with Alzheimer's disease." Human molecular genetics 12 (8) doi:
Sáez-Valero Javier, Costell Mercedes, Sjögren Magnus, Andreasen Niels, Blennow Kaj, Luque Juan M 2003. "Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease." Journal of neuroscience research 72 (1) doi:10.1002/jnr.10554
Wahlund Lars-Olov, Blennow Kaj 2003. "Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients." Neuroscience letters 339 (2) doi:
Paulson Linda, Martin Peter, Persson Anders, Nilsson Carol L, Ljung Elisabeth, et al. 2003. "Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats." Journal of neuroscience research 71 (4) doi:10.1002/jnr.10509
Hamberger Anders, Huang Ying-Lai, Zhu Hong, Bao Feng, Ding Mei, et al. 2003. "Redistribution of neurofilaments and accumulation of beta-amyloid protein after brain injury by rotational acceleration of the head." Journal of neurotrauma 20 (2) doi:10.1089/08977150360547080
Holmberg Björn, Johnels Bo, Blennow Kaj, Rosengren Lars 2003. "Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy." Movement disorders : official journal of the Movement Disorder Society 18 (2) doi:10.1002/mds.10321
Olsson Annika, Vanmechelen Eugeen, Vanderstichele Hugo, Davidsson Pia, Blennow Kaj 2003. "Unaltered plasma levels of beta-amyloid(1-40) and beta-amyloid(1-42) upon stimulation of human platelets." Dementia and geriatric cognitive disorders 16 (2) doi:70681
Lehmann Martin, Regland Björn, Blennow Kaj, Gottfries C G 2003. "Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment." Dementia and geriatric cognitive disorders 16 (3) doi:71002
Sjögren Magnus, Gustafsson Kina, Syversen Steinar, Olsson Annika, Edman Ake, et al. 2003. "Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein." Dementia and geriatric cognitive disorders 16 (1) doi:69989
Andreasen Niels, Vanmechelen Eugeen, Vanderstichele Hugo, Davidsson Pia, Blennow Kaj 2003. "Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment." Acta neurologica Scandinavica. Supplementum 179 doi:
Wallin Anders, Sjögren Magnus, Blennow Kaj, Davidsson Pia 2003. "Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia." Dementia and geriatric cognitive disorders 16 (4) doi:72803
Feuk Lars, Prince Jonathan A, Blennow Kaj, Brookes Anthony J 2003. "Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease." Human mutation 21 (1) doi:10.1002/humu.10148

2002

Davidsson Pia, Sjögren Magnus, Andreasen Niels, Lindbjer Maria, Nilsson Carol L, et al. 2002. "Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins." Brain research. Molecular brain research 109 (1-2) doi:
Buerger Katharina, Zinkowski Raymond, Teipel Stefan J, Tapiola Tero, Arai Hiroyuki, et al. 2002. "Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231." Archives of neurology 59 (8) doi:
Andreasen Niels, Blennow Kaj 2002. "Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease." Peptides 23 (7) doi:
Zetterberg Henrik, Palmér Mona, Ricksten Anne, Poirier Judes, Palmqvist Lars, et al. 2002. "Influence of the apolipoprotein E epsilon4 allele on human embryonic development." Neuroscience letters 324 (3) doi:
Sjögren Magnus, Blennow Kaj 2002. "[A new putative principle for diagnosis of Creutzfeldt-Jakob disease]." Läkartidningen 99 (21) doi:
Landén Mikael, Davidsson Pia, Gottfries Carl-Gerhard, Månsson Jan-Eric, Blennow Kaj 2002. "Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia." Schizophrenia research 55 (1-2) doi:
Davidsson Pia, Westman-Brinkmalm Ann, Nilsson Carol L, Lindbjer Maria, Paulson Linda, et al. 2002. "Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients." Neuroreport 13 (5) doi:
Zetterberg Henrik, Regland Björn, Palmér Mona, Ricksten Anne, Palmqvist Lars, et al. 2002. "Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos." European journal of human genetics : EJHG 10 (2) doi:10.1038/sj.ejhg.5200767
Berggren Ulf, Eriksson Matts, Fahlke Claudia, Blennow Kaj, Sundkler Anders, Balldin Jan 2002. "Platelet monoamine oxidase-B activity in type 1 alcohol-dependent subjects in sustained full remission." Alcohol and alcoholism (Oxford, Oxfordshire) 37 (4) doi:
Sundman-Eriksson Ingrid, Blennow Kaj, Davidsson Pia, Dandenell Anna-Karin, Marcusson Jan 2002. "Increased [(3)H]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia." Neuropsychobiology 45 (1) doi:
Mathé Aleksander A, Agren Hans, Wallin Anders, Blennow Kaj 2002. "Calcitonin gene-related peptide and calcitonin in the CSF of patients with dementia and depression: possible disease markers." Progress in neuro-psychopharmacology & biological psychiatry 26 (1) doi:
Sjögren Magnus, Davidsson Pia, Wallin Anders, Granérus Ann-Kathrine, Grundström Eva, et al. 2002. "Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms." Dementia and geriatric cognitive disorders 13 (2) doi:48642
Tarkowski Elisabeth, Issa Razao, Sjögren Magnus, Wallin Anders, Blennow Kaj, et al. 2002. "Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia." Neurobiology of aging 23 (2) doi:
Nägga Katarina, Gottfries Johan, Blennow Kaj, Marcusson Jan 2002. "Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia." Dementia and geriatric cognitive disorders 14 (4) doi:66023
Sjögren Magnus, Wikkelsö Carsten, Ostling Svante, Wallin Anders, Blennow Kaj 2002. "Biological correlates of clinical subgroups of Alzheimer's disease." Dementia and geriatric cognitive disorders 14 (4) doi:66025
Berggren Ulf, Eriksson Matts, Fahlke Claudia, Blennow Kaj, Balldin Jan 2002. "Platelet monoamine oxidase B in family history positive and family history negative type 1 alcohol-dependent subjects." Alcohol and alcoholism (Oxford, Oxfordshire) 37 (6) doi: